isoproterenol has been researched along with Atrial Fibrillation in 212 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both isoproterenol (Iso) and adenosine (Ado) are used to induce atrial fibrillation (AF) in the electrophysiology lab." | 9.30 | Is adenosine useful for the identification of atrial fibrillation triggers? ( Bencsik, G; Makai, A; Pap, R; Riesz, T; Saghy, L; Tutuianu, C, 2019) |
| "Adenosine can reveal dormant pulmonary vein (PV) conduction after PV isolation (PVI) in patients with paroxysmal atrial fibrillation (AF)." | 9.22 | Role of adenosine after antral pulmonary vein isolation of paroxysmal atrial fibrillation: A randomized controlled trial. ( Al-Assad, W; Ansari, S; Bogun, F; Chugh, A; Crawford, T; Ghanbari, H; Huether, E; Hussain-Amin, A; Jani, R; Jongnarangsin, K; Latchamsetty, R; Morady, F; Oral, H, 2016) |
| "We enrolled 112 LSPAF patients on amiodarone and scheduled to undergo atrial fibrillation (AF) ablation." | 9.20 | Effect of periprocedural amiodarone on procedure outcome in patients with longstanding persistent atrial fibrillation undergoing extended pulmonary vein antrum isolation: results from a randomized study (SPECULATE). ( Al-Ahmad, A; Bai, R; Beheiry, S; Burkhardt, JD; Casella, M; Dello Russo, A; Di Biase, L; Forleo, G; Gallinghouse, JG; Hongo, R; Horton, R; Hranitzky, PM; Lakkireddy, D; Mohanty, P; Mohanty, S; Natale, A; Pelargonio, G; Reddy, M; Rossillo, A; Sanchez, JE; Santangeli, P; Themistoclakis, S; Tondo, C; Trivedi, C; Zagrodzky, J, 2015) |
| "Isoproterenol infusion alters consciousness level during total intravenous anesthesia for atrial fibrillation ablation." | 9.16 | Isoproterenol infusion increases level of consciousness during catheter ablation of atrial fibrillation. ( Aizer, A; Bloom, M; Chinitz, L; Linton, P; O'Neill, DK; Rose, E, 2012) |
| "To determine the sensitivity and specificity of isoproterenol for the induction of atrial fibrillation (AF)." | 9.13 | Inducibility of paroxysmal atrial fibrillation by isoproterenol and its relation to the mode of onset of atrial fibrillation. ( Bogun, F; Chalfoun, N; Chugh, A; Crawford, T; Dey, S; Frederick, M; Gadeela, N; Good, E; Jongnarangsin, K; Kuhne, M; Morady, F; Oral, H; Pelosi, F; Sarrazin, JF; Wells, D; Wimmer, A, 2008) |
| "High-dose isoproterenol infusion is a useful provocative maneuver to elicit triggers of atrial fibrillation (AF) during ablation." | 8.31 | Association of isoproterenol infusion during catheter ablation of atrial fibrillation with outcomes: insights from the UC San Diego AF Ablation Registry. ( Aldaas, OM; Darden, D; Feld, GK; Han, FT; Ho, G; Hoffmayer, KS; Hsu, JC; Krummen, D; Mylavarapu, PS; Raissi, F, 2023) |
| "The CARTOFINDER mapping system analyzes activation patterns using unipolar potentials during atrial fibrillation (AF), where isoproterenol (ISP) is conventionally used to induce non-pulmonary vein (PV) foci and confirm PV arrhythmogenicity." | 8.12 | Evaluation of arrhythmogenic foci using a novel automated detection algorithm and isoproterenol in persistent atrial fibrillation. ( Ajioka, M; Asano, H; Hiramatsu, S; Kanbara, T; Kondo, S; Nakashima, Y; Osanai, H; Sakamoto, Y, 2022) |
| "Inflammation can contribute to the initiation and progression of atrial fibrillation (AF), and pinocembrin can suppress downstream inflammatory cytokine production by inhibiting the inflammation pathway." | 8.12 | Pinocembrin alleviates the susceptibility to atrial fibrillation in isoproterenol-induced rats. ( Chen, X; Liu, Z; Wan, W; Yang, B; Ye, T; Yu, Y; Zhang, C, 2022) |
| "The antihistaminic antazoline (ANT) was reported to be highly effective and safe for rapid conversion of atrial fibrillation (AF)." | 7.85 | Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent. ( Bögeholz, N; Bogossian, H; Dechering, DG; Eckardt, L; Fehr, M; Frommeyer, G; Kaese, S; Milberg, P; Pott, C; Sterneberg, M, 2017) |
| "The aim of the present study was to confirm the effect of Tanshinone IIA (TAN) on the prevention of AF in chronic heart failure (CHF), and to elucidate the underlying electrophysiological mechanisms for the antiarrhythmic effects of TAN at the level of the atrium in an experimental model of CHF." | 7.83 | Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure. ( Cheng, D; He, Z; Sun, C; Xu, Y, 2016) |
| "Ranolazine (RAN) was reported to be effective and safe in converting atrial fibrillation (AF) to sinus rhythm by administration of a single dose ('pill in the pocket') to patients with structural heart disease." | 7.78 | Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure. ( Clauß, C; Eckardt, L; Frommeyer, G; Kaese, S; Milberg, P; Pott, C; Schmidt, M; Stypmann, J, 2012) |
| "The effects of adenosine infusion, isoproterenol infusion, or both were evaluated in 53 patients with refractory atrial fibrillation referred for ablation." | 7.73 | [Inducibility of atrial arrhythmias after adenosine and isoproterenol infusion in patients referred for atrial fibrillation ablation]. ( Alonso, R; Doblado, M; Isa-Param, R; Macaya, C; Morales, R; Moreno, J; Pérez-Castellano, N; Ruiz, E; Salinas, J; Villacastín, J, 2006) |
| "A perfusion with normal Tirode solution containing isoproterenol, acetylcholine and their combination into the sinus node artery of the anesthetized open-chest dogs was used to induce atrial fibrillation." | 7.71 | [Isoproterenol potentiates atrial fibrillation induced by acetylcholine]. ( Beloshapko, GG; Fedorov, VV; Iushmanova, AV; Rozenshtraukh, LV; Sharifov, OF, 2001) |
| "(1) To investigate the electrophysiological effects of flecainide and propafenone during atrial fibrillation, and their relation to arrhythmia termination; (2) to investigate the effects of isoprenaline on atrial fibrillation in basal conditions and during treatment with class 1C drugs to evaluate the role of adrenergic stimulation on proarrhythmic events occurring during this treatment." | 7.70 | Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. ( Biffi, M; Boriani, G; Branzi, A; Bronzetti, G; Capucci, A; Magnani, B, 1999) |
| "In order to evaluate the effects of increases of sympathetic tone in ventricular response during atrial fibrillation and in the relationship between the accessory pathway effective refractory period (ERP) and ventricular rate during atrial fibrillation, 20 male subjects, aged 19 +/- 6 years, were studied electrophysiologically in basal conditions, after isoproterenol infusion (2-4 micrograms/min) and during submaximal bicycle exercise test, at a constant workload equal to that which increases the sinus rate to the same extent (140 beats/min) induced by isoproterenol infusion." | 7.68 | Comparison of isoproterenol and exercise tests in asymptomatic subjects with Wolff-Parkinson-White syndrome. ( Chimienti, M; Klersy, C; Li Bergolis, M; Moizi, M; Negroni, MS; Salerno, JA, 1992) |
| "Clinical experience has shown that the antiarrhythmic effect of lidocaine on atrial arrhythmias, and specifically for the conversion of atrial fibrillation to normal sinus rhythm, is minimal." | 7.68 | Parasympathetically modulated antiarrhythmic action of lidocaine in atrial fibrillation. ( Akselrod, S; Borow, KM; David, D; Lang, RM; Mor-Avi, V; Neumann, A, 1990) |
| "The mechanism of atrial flutter and fibrillation induced by rapid pacing in 22 dogs with 3-day-old sterile pericarditis was investigated by computerized epicardial mapping of atrial activation before and after administration of agents known to modify atrial electrophysiologic properties: procainamide, isoproterenol, and electrical stimulation of the vagosympathetic trunks." | 7.68 | Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis. ( Cardinal, R; Hassanalizadeh, H; Pagé, PL, 1991) |
| "The ultrashort-acting beta blocker flestolol was studied during atrial pacing and atrial fibrillation (AF) in 10 patients with Wolff-Parkinson-White syndrome." | 7.67 | Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome. ( Liem, LB; Peterson, J; Swerdlow, CD, 1988) |
| "The effects of physical exercise, isoproterenol and atropine upon the ventricular rate and regularity were studied in 12 patients with atrial fibrillation (AF) during verapamil-induced regular ventricular rhythm." | 7.66 | Verapamil-induced ventricular regularity in atrial fibrillation. Effects of exercise, isoproterenol, atropine and conversion to sinus rhythm. ( Khalsa, A; Olsson, SB, 1979) |
| "The effects of exercise and isoproterenol on atrial fibrillation (AF) were studied in 17 patients with Wolff-Parkinson-White syndrome (WPW) to assess the risk of developing a rapid ventricular response." | 7.66 | Effects of exercise and isoproterenol during atrial fibrillation in patients with Wolff-Parkinson-White syndrome. ( Broughton, A; Gallagher, JJ; German, LD; Guarnieri, T; Trantham, JL, 1983) |
| "However, postoperative recurrence is a serious issue caused by the reconduction of the isolated pulmonary veins (PV) and the onset of non-PV foci." | 5.56 | Efficacy of isoproterenol in the evaluation of dormant conduction and arrhythmogenic foci identification in atrial fibrillation ablation. ( Ajioka, M; Asano, H; Hiramatsu, S; Hosono, H; Kanbara, T; Kondo, S; Kurokawa, H; Matsumoto, H; Miyamoto, S; Nakashima, Y; Osanai, H; Sakamoto, Y; Tagahara, K; Tokuda, K; Uno, H, 2020) |
| "Both isoproterenol (Iso) and adenosine (Ado) are used to induce atrial fibrillation (AF) in the electrophysiology lab." | 5.30 | Is adenosine useful for the identification of atrial fibrillation triggers? ( Bencsik, G; Makai, A; Pap, R; Riesz, T; Saghy, L; Tutuianu, C, 2019) |
| "Sotalol has Class II and III antiarrhythmic effects." | 5.28 | Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol. ( Madrid, AH; Maŕin Huerta, EM; Mestre, JL; Moro, C; Novo, L, 1992) |
| "During AF in WPW syndrome, the ventricular rate is related to the duration of the anterograde refractory period of the accessory pathway." | 5.27 | Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome. ( Abdollah, H; Brugada, P; Wellens, HJ, 1983) |
| "Adenosine can reveal dormant pulmonary vein (PV) conduction after PV isolation (PVI) in patients with paroxysmal atrial fibrillation (AF)." | 5.22 | Role of adenosine after antral pulmonary vein isolation of paroxysmal atrial fibrillation: A randomized controlled trial. ( Al-Assad, W; Ansari, S; Bogun, F; Chugh, A; Crawford, T; Ghanbari, H; Huether, E; Hussain-Amin, A; Jani, R; Jongnarangsin, K; Latchamsetty, R; Morady, F; Oral, H, 2016) |
| "We enrolled 112 LSPAF patients on amiodarone and scheduled to undergo atrial fibrillation (AF) ablation." | 5.20 | Effect of periprocedural amiodarone on procedure outcome in patients with longstanding persistent atrial fibrillation undergoing extended pulmonary vein antrum isolation: results from a randomized study (SPECULATE). ( Al-Ahmad, A; Bai, R; Beheiry, S; Burkhardt, JD; Casella, M; Dello Russo, A; Di Biase, L; Forleo, G; Gallinghouse, JG; Hongo, R; Horton, R; Hranitzky, PM; Lakkireddy, D; Mohanty, P; Mohanty, S; Natale, A; Pelargonio, G; Reddy, M; Rossillo, A; Sanchez, JE; Santangeli, P; Themistoclakis, S; Tondo, C; Trivedi, C; Zagrodzky, J, 2015) |
| "To evaluate the incidence and clinical outcome of adenosine triphosphate (ATP) plus isoproterenol (ISP)-induced non-pulmonary vein (PV) foci before and after circumferential PV isolation (CPVI) during index ablation in patients with paroxysmal atrial fibrillation (PAF)." | 5.19 | Non-pulmonary vein foci induced before and after pulmonary vein isolation in patients undergoing ablation therapy for paroxysmal atrial fibrillation: incidence and clinical outcome. ( Chen, SQ; Cheng, H; Dai, YY; Jiang, CY; Jiang, RH; Lin, JW; Liu, Q; Sheng, X; Sun, YX; Zhang, ZW; Zhu, J, 2014) |
| "Isoproterenol infusion alters consciousness level during total intravenous anesthesia for atrial fibrillation ablation." | 5.16 | Isoproterenol infusion increases level of consciousness during catheter ablation of atrial fibrillation. ( Aizer, A; Bloom, M; Chinitz, L; Linton, P; O'Neill, DK; Rose, E, 2012) |
| "To determine the sensitivity and specificity of isoproterenol for the induction of atrial fibrillation (AF)." | 5.13 | Inducibility of paroxysmal atrial fibrillation by isoproterenol and its relation to the mode of onset of atrial fibrillation. ( Bogun, F; Chalfoun, N; Chugh, A; Crawford, T; Dey, S; Frederick, M; Gadeela, N; Good, E; Jongnarangsin, K; Kuhne, M; Morady, F; Oral, H; Pelosi, F; Sarrazin, JF; Wells, D; Wimmer, A, 2008) |
| "During ablation of LSP atrial fibrillation, in addition to pulmonary vein antrum and posterior wall isolation, ablation of nonpulmonary vein triggers disclosed by high dosage of isoproterenol seems to be of utmost importance to achieve long-term success after a single procedure." | 4.89 | How to ablate long-standing persistent atrial fibrillation? ( Di Biase, L; Natale, A; Santangeli, P, 2013) |
| "High-dose isoproterenol infusion is a useful provocative maneuver to elicit triggers of atrial fibrillation (AF) during ablation." | 4.31 | Association of isoproterenol infusion during catheter ablation of atrial fibrillation with outcomes: insights from the UC San Diego AF Ablation Registry. ( Aldaas, OM; Darden, D; Feld, GK; Han, FT; Ho, G; Hoffmayer, KS; Hsu, JC; Krummen, D; Mylavarapu, PS; Raissi, F, 2023) |
| "Inflammation can contribute to the initiation and progression of atrial fibrillation (AF), and pinocembrin can suppress downstream inflammatory cytokine production by inhibiting the inflammation pathway." | 4.12 | Pinocembrin alleviates the susceptibility to atrial fibrillation in isoproterenol-induced rats. ( Chen, X; Liu, Z; Wan, W; Yang, B; Ye, T; Yu, Y; Zhang, C, 2022) |
| "The CARTOFINDER mapping system analyzes activation patterns using unipolar potentials during atrial fibrillation (AF), where isoproterenol (ISP) is conventionally used to induce non-pulmonary vein (PV) foci and confirm PV arrhythmogenicity." | 4.12 | Evaluation of arrhythmogenic foci using a novel automated detection algorithm and isoproterenol in persistent atrial fibrillation. ( Ajioka, M; Asano, H; Hiramatsu, S; Kanbara, T; Kondo, S; Nakashima, Y; Osanai, H; Sakamoto, Y, 2022) |
| "The antihistaminic antazoline (ANT) was reported to be highly effective and safe for rapid conversion of atrial fibrillation (AF)." | 3.85 | Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent. ( Bögeholz, N; Bogossian, H; Dechering, DG; Eckardt, L; Fehr, M; Frommeyer, G; Kaese, S; Milberg, P; Pott, C; Sterneberg, M, 2017) |
| "The aim of the present study was to confirm the effect of Tanshinone IIA (TAN) on the prevention of AF in chronic heart failure (CHF), and to elucidate the underlying electrophysiological mechanisms for the antiarrhythmic effects of TAN at the level of the atrium in an experimental model of CHF." | 3.83 | Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure. ( Cheng, D; He, Z; Sun, C; Xu, Y, 2016) |
| "Ranolazine (RAN) was reported to be effective and safe in converting atrial fibrillation (AF) to sinus rhythm by administration of a single dose ('pill in the pocket') to patients with structural heart disease." | 3.78 | Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure. ( Clauß, C; Eckardt, L; Frommeyer, G; Kaese, S; Milberg, P; Pott, C; Schmidt, M; Stypmann, J, 2012) |
| " dl-Sotalol (SOT) is a β-blocker commonly used in the rhythm-control treatment of atrial fibrillation." | 3.78 | Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations. ( Antzelevitch, C; Gibson, JK; Lynch, JJ; Pourrier, M; Sicouri, S, 2012) |
| "We performed 3D endocardial mapping in healthy controls (group 1, n=10) and patients with AF without (group 2, n=57) or with (group 3, n=15) symptomatic bradycardia at baseline and during isoproterenol infusion." | 3.77 | Abnormal response of superior sinoatrial node to sympathetic stimulation is a characteristic finding in patients with atrial fibrillation and symptomatic bradycardia. ( Chen, PS; Hwang, HJ; Joung, B; Lee, MH; Lin, SF; Pak, HN; Shen, C, 2011) |
| "Endothelin-1 (ET-1) is elevated in patients with atrial fibrillation (AF) and heart failure." | 3.73 | Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. ( Kane, KA; Rankin, AC; Redpath, CJ; Workman, AJ, 2006) |
| "The effects of adenosine infusion, isoproterenol infusion, or both were evaluated in 53 patients with refractory atrial fibrillation referred for ablation." | 3.73 | [Inducibility of atrial arrhythmias after adenosine and isoproterenol infusion in patients referred for atrial fibrillation ablation]. ( Alonso, R; Doblado, M; Isa-Param, R; Macaya, C; Morales, R; Moreno, J; Pérez-Castellano, N; Ruiz, E; Salinas, J; Villacastín, J, 2006) |
| " Recordings of 9 patients suffering from paroxysmal atrial fibrillation were tested during four clinical experimental conditions: sinus rhythm and atrial fibrillation, both before and after isoproterenol infusion, a drug mimicking adrenergic activation." | 3.73 | Assessment of spatial organization in the atria during paroxysmal atrial fibrillation and adrenergic stimulation. ( Corino, VD; Lombardi, F; Mainardi, LT; Mantica, M, 2006) |
| "Short-term infusion of low-dose isoproterenol improved atrial function after cardioversion of chronic atrial fibrillation and atrial flutter." | 3.71 | Effect of low-dose isoproterenol infusion on left atrial appendage function soon after cardioversion of chronic atrial tachyarrhythmias. ( Date, T; Iesaka, Y; Ishikawa, S; Kanae, K; Miyazaki, H; Mochizuki, S; Noma, K; Nuruiki, N; Takahashi, A; Yamane, T, 2002) |
| "A perfusion with normal Tirode solution containing isoproterenol, acetylcholine and their combination into the sinus node artery of the anesthetized open-chest dogs was used to induce atrial fibrillation." | 3.71 | [Isoproterenol potentiates atrial fibrillation induced by acetylcholine]. ( Beloshapko, GG; Fedorov, VV; Iushmanova, AV; Rozenshtraukh, LV; Sharifov, OF, 2001) |
| "(1) To investigate the electrophysiological effects of flecainide and propafenone during atrial fibrillation, and their relation to arrhythmia termination; (2) to investigate the effects of isoprenaline on atrial fibrillation in basal conditions and during treatment with class 1C drugs to evaluate the role of adrenergic stimulation on proarrhythmic events occurring during this treatment." | 3.70 | Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. ( Biffi, M; Boriani, G; Branzi, A; Bronzetti, G; Capucci, A; Magnani, B, 1999) |
| "In order to evaluate the effects of increases of sympathetic tone in ventricular response during atrial fibrillation and in the relationship between the accessory pathway effective refractory period (ERP) and ventricular rate during atrial fibrillation, 20 male subjects, aged 19 +/- 6 years, were studied electrophysiologically in basal conditions, after isoproterenol infusion (2-4 micrograms/min) and during submaximal bicycle exercise test, at a constant workload equal to that which increases the sinus rate to the same extent (140 beats/min) induced by isoproterenol infusion." | 3.68 | Comparison of isoproterenol and exercise tests in asymptomatic subjects with Wolff-Parkinson-White syndrome. ( Chimienti, M; Klersy, C; Li Bergolis, M; Moizi, M; Negroni, MS; Salerno, JA, 1992) |
| "The mechanism of atrial flutter and fibrillation induced by rapid pacing in 22 dogs with 3-day-old sterile pericarditis was investigated by computerized epicardial mapping of atrial activation before and after administration of agents known to modify atrial electrophysiologic properties: procainamide, isoproterenol, and electrical stimulation of the vagosympathetic trunks." | 3.68 | Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis. ( Cardinal, R; Hassanalizadeh, H; Pagé, PL, 1991) |
| " Three bipolar epicardial electrodes recorded left atrial and left and right ventricular depolarizations simultaneously during normal sinus rhythm (NSR) (mean of 5 beats in 11/11 dogs), ST produced by phlebotomy (50 beats in 10 episodes in 6/11) or isoproterenol infusion (105 beats in 21 episodes in 10/11), sinus bradycardia (SB) produced by vagal stimulation (140 beats in 29 episodes in 10/11), and during atrial flutter (AFL) (15 beats in 3 episodes in 3/11) and atrial fibrillation (AF) (152 beats in 31 episodes in 9/11) induced by programmed electrical stimulation." | 3.68 | Differentiation of sinus rhythms from supraventricular tachydysrhythmias by activation sequence and timing. ( Furman, S; Mercando, AD; Singer, LP; Walsh, CA, 1990) |
| "Clinical experience has shown that the antiarrhythmic effect of lidocaine on atrial arrhythmias, and specifically for the conversion of atrial fibrillation to normal sinus rhythm, is minimal." | 3.68 | Parasympathetically modulated antiarrhythmic action of lidocaine in atrial fibrillation. ( Akselrod, S; Borow, KM; David, D; Lang, RM; Mor-Avi, V; Neumann, A, 1990) |
| "The ultrashort-acting beta blocker flestolol was studied during atrial pacing and atrial fibrillation (AF) in 10 patients with Wolff-Parkinson-White syndrome." | 3.67 | Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome. ( Liem, LB; Peterson, J; Swerdlow, CD, 1988) |
| "The effects of physical exercise, isoproterenol and atropine upon the ventricular rate and regularity were studied in 12 patients with atrial fibrillation (AF) during verapamil-induced regular ventricular rhythm." | 3.66 | Verapamil-induced ventricular regularity in atrial fibrillation. Effects of exercise, isoproterenol, atropine and conversion to sinus rhythm. ( Khalsa, A; Olsson, SB, 1979) |
| "The effects of exercise and isoproterenol on atrial fibrillation (AF) were studied in 17 patients with Wolff-Parkinson-White syndrome (WPW) to assess the risk of developing a rapid ventricular response." | 3.66 | Effects of exercise and isoproterenol during atrial fibrillation in patients with Wolff-Parkinson-White syndrome. ( Broughton, A; Gallagher, JJ; German, LD; Guarnieri, T; Trantham, JL, 1983) |
| "We hypothesized that in patients with paroxysmal atrial fibrillation (AF) apparently originating in the left pulmonary veins, mapping through the distal coronary sinus might identify possible epicardial locations of the arrhythmogenic focus." | 2.70 | Epicardial foci of atrial arrhythmias apparently originating in the left pulmonary veins. ( Anagnostopoulos, CE; Camm, AJ; Giazitzoglou, E; Katritsis, D; Korovesis, S; Paxinos, G, 2002) |
| "However, postoperative recurrence is a serious issue caused by the reconduction of the isolated pulmonary veins (PV) and the onset of non-PV foci." | 1.56 | Efficacy of isoproterenol in the evaluation of dormant conduction and arrhythmogenic foci identification in atrial fibrillation ablation. ( Ajioka, M; Asano, H; Hiramatsu, S; Hosono, H; Kanbara, T; Kondo, S; Kurokawa, H; Matsumoto, H; Miyamoto, S; Nakashima, Y; Osanai, H; Sakamoto, Y; Tagahara, K; Tokuda, K; Uno, H, 2020) |
| "Age- and sex-adjusted hazards for AF recurrence were also similar between the 2 groups." | 1.51 | Outcomes After Atrial Fibrillation Ablation in Patients With Premature Atrial Contractions Originating From Non-Pulmonary Veins. ( Fujii, K; Hirao, Y; Inoue, H; Inoue, K; Iwakura, K; Koyama, Y; Nakamaru, R; Ninomiya, Y; Oka, T; Okada, M; Okamura, A; Rakugi, H; Sakata, Y; Takayasu, K; Tanaka, K; Tanaka, N, 2019) |
| "Isoproterenol was infused up to 20μg/min to provoke ectopy and AF." | 1.48 | Comparison of the origin and coupling interval between ectopy with and without atrial fibrillation initiation. ( Fujita, M; Iida, O; Ishihara, T; Kanda, T; Masuda, M; Matsuda, Y; Nanto, K; Ohashi, T; Okamoto, S; Sunaga, A; Tsujimura, T; Uematsu, M, 2018) |
| "Isoproterenol was infused for induction, and the triggering PV was identified." | 1.43 | Association between dissociated firing in isolated pulmonary veins and the initiation and maintenance of atrial fibrillation. ( Bencsik, G; Klausz, G; Pap, R; Sághy, L; Traykov, V; Tutuianu, C, 2016) |
| "Dyslipidemia is an important factor in MetS and is related to atrial fibrillation (AF)." | 1.43 | VLDL from Metabolic Syndrome Individuals Enhanced Lipid Accumulation in Atria with Association of Susceptibility to Atrial Fibrillation. ( Chen, CH; Chu, CS; Hsiao, YL; Ke, LY; Lai, WT; Lee, HC; Lin, HT; Sheu, SH; Shin, SJ; Wei, C; Wu, BN, 2016) |
| "AF recurrence was documented in eight of 16 patients with, but only in three of 28 patients without acute reconnection (p = 0." | 1.40 | Acute pulmonary vein reconnection is a predictor of atrial fibrillation recurrence following pulmonary vein isolation. ( Anter, E; Contreras-Valdes, FM; Josephson, ME; Shvilkin, A; Tschabrunn, CM, 2014) |
| "Obesity is an important risk factor for atrial fibrillation (AF)." | 1.38 | Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation. ( Chen, JH; Chen, SA; Chen, YC; Chen, YJ; Lin, YK, 2012) |
| "With isoproterenol infusion, the increase of LAAEV was greater in group 1 than in group 2." | 1.35 | Prognostic implication of the left atrial appendage mechanical reserve after cardioversion of atrial fibrillation. ( Kim, YH; Lim, DS; Lim, HE; Oh, WJ; Pak, HN; Park, MY; Ro, YM; Shim, WJ; Shin, SH, 2008) |
| "Isoproterenol was not required in five children younger than 10 years old, because they developed a catecholaminergic sinus tachycardia." | 1.34 | Interest of non-invasive and semi-invasive testings in asymptomatic children with pre-excitation syndrome. ( Abbas, M; Ammar, S; Bertrand, J; Beurrier, D; Brembilla-Perrot, B; Cedano, J; Chometon, F; Cloez, JL; Duhoux, F; Groben, L; Huttin, O; Marcha, C; Marçon, F; Tatar, C; Terrier de Chaise, A; Tisserand, A; Yangni N'da, O; Zhang, N, 2007) |
| "Verapamil did not cause a significant change either in the SN or in the PVD cycle length." | 1.33 | Response to pharmacological challenge of dissociated pulmonary vein rhythm. ( Abdul-Karim, A; Bhargava, M; Burkhardt, D; Erciyes, D; Khaykin, Y; Marrouche, N; Martin, DO; Natale, A; Rossillo, A; Saliba, W; Schweikert, R; Verma, A; Wazni, OM, 2005) |
| "Isoproterenol treatment showed antagonistic effect against endothelin-1 induced MAP duration prolongation, early after depolarisation and ventricular fibrillation formation, while endothelin-1 showed protective effect against the development of isoproterenol induced atrial fibrillation." | 1.32 | Intracoronary endothelin-1 infusion combined with systemic isoproterenol treatment: antagonistic arrhythmogenic effects. ( Juhász-Nagy, A; Kékesi, V; Kiss, O; Merkely, B; Soós, P; Zima, E, 2004) |
| "Treatment with ryanodine (0." | 1.32 | Pacing-induced spontaneous activity in myocardial sleeves of pulmonary veins after treatment with ryanodine. ( Boyett, MR; Honjo, H; Horiuchi, T; Inada, S; Kamiya, K; Kodama, I; Mitsui, K; Niwa, R; Shibata, N; Yamamoto, M, 2003) |
| "Atropine (1 to 2 mg) treatment prevented catecholamine-mediated AF, indicating a critical role of cholinergic tone in these AF episodes." | 1.32 | Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs. ( Beloshapko, GG; Fedorov, VV; Glukhov, AV; Rosenshtraukh, LV; Sharifov, OF; Yushmanova, AV, 2004) |
| "The tachyarrhythmias were suppressed by sodium channel blocker, potassium channel blocker or magnesium." | 1.31 | Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation. ( Chang, MS; Chen, SA; Chen, YJ; Lin, CI, 2000) |
| "In patients with persistent atrial fibrillation (AF), the atrial myocardium is characterized by a reduced contractile force, by a shortened duration of the action potential and a recently demonstrated reduction of the L-type Ca2+ currents." | 1.31 | L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation. ( Jüngling, E; Lückhoff, A; Picht, E; Schöndube, F; Skasa, M, 2001) |
| "Twenty-eight patients with paroxysmal atrial fibrillation (9 patients were categorized to have autonomic-mediated atrial fibrillation while atrial fibrillation in other patients was nonautonomic mediated) and 19 normal control subjects were recruited." | 1.30 | Abnormal vasovagal reaction, autonomic function, and heart rate variability in patients with paroxysmal atrial fibrillation. ( Lau, CP; Lok, NS, 1998) |
| "Patients with syncope associated with paroxysmal atrial fibrillation are predisposed to an abnormal neural response during both sinus rhythm and arrhythmia." | 1.29 | Role of autonomic reflexes in syncope associated with paroxysmal atrial fibrillation. ( Bottoni, N; Brignole, M; Gianfranchi, L; Lolli, G; Menozzi, C; Oddone, D; Raviele, A, 1993) |
| "Sotalol has Class II and III antiarrhythmic effects." | 1.28 | Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol. ( Madrid, AH; Maŕin Huerta, EM; Mestre, JL; Moro, C; Novo, L, 1992) |
| "During AF in WPW syndrome, the ventricular rate is related to the duration of the anterograde refractory period of the accessory pathway." | 1.27 | Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome. ( Abdollah, H; Brugada, P; Wellens, HJ, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 63 (29.72) | 18.7374 |
| 1990's | 24 (11.32) | 18.2507 |
| 2000's | 55 (25.94) | 29.6817 |
| 2010's | 50 (23.58) | 24.3611 |
| 2020's | 20 (9.43) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, JP | 1 |
| Burrows, A | 1 |
| Gallotti, RG | 1 |
| Shannon, KM | 1 |
| Sakamoto, Y | 2 |
| Osanai, H | 2 |
| Hiramatsu, S | 2 |
| Kondo, S | 2 |
| Kanbara, T | 2 |
| Nakashima, Y | 2 |
| Asano, H | 2 |
| Ajioka, M | 2 |
| O'Neill, L | 1 |
| Sim, I | 1 |
| O'Hare, D | 1 |
| Whitaker, J | 1 |
| Mukherjee, RK | 1 |
| Niederer, S | 1 |
| Wright, M | 2 |
| Ezzat, V | 1 |
| Rosenthal, E | 1 |
| Jones, MI | 1 |
| Frigiola, A | 1 |
| O'Neill, MD | 2 |
| Williams, SE | 1 |
| Liu, Z | 1 |
| Chen, X | 1 |
| Ye, T | 1 |
| Wan, W | 1 |
| Yu, Y | 1 |
| Zhang, C | 1 |
| Yang, B | 1 |
| Takahashi, T | 1 |
| Kusunose, K | 1 |
| Hayashi, S | 1 |
| Zheng, R | 1 |
| Yamaguchi, N | 1 |
| Morita, S | 1 |
| Hirata, Y | 1 |
| Nishio, S | 1 |
| Saijo, Y | 1 |
| Ise, T | 1 |
| Yamaguchi, K | 1 |
| Yagi, S | 1 |
| Yamada, H | 1 |
| Soeki, T | 1 |
| Wakatsuki, T | 1 |
| Sata, M | 1 |
| Di Pino, A | 6 |
| Oreto, L | 3 |
| Aldaas, OM | 2 |
| Darden, D | 2 |
| Mylavarapu, PS | 2 |
| Han, FT | 2 |
| Hoffmayer, KS | 2 |
| Krummen, D | 2 |
| Ho, G | 3 |
| Raissi, F | 2 |
| Feld, GK | 2 |
| Hsu, JC | 2 |
| Yamashita, E | 2 |
| Kemi, Y | 2 |
| Sasaki, T | 3 |
| Minami, K | 3 |
| Goto, K | 2 |
| Miki, Y | 2 |
| Nakatani, Y | 2 |
| Take, Y | 2 |
| Nakamura, K | 2 |
| Kario, K | 2 |
| Naito, S | 2 |
| Goyal, SK | 1 |
| Hyder, S | 1 |
| Liu, S | 1 |
| Vannan, MA | 1 |
| Iskakov, NG | 1 |
| Anikina, TA | 1 |
| Sitdikov, FG | 1 |
| Zefirov, TL | 1 |
| Celotto, C | 2 |
| Sánchez, C | 2 |
| Mountris, KA | 2 |
| Laguna, P | 2 |
| Pueyo, E | 2 |
| Machino-Ohtsuka, T | 1 |
| Yamasaki, H | 1 |
| Nakatsukasa, T | 1 |
| Kawamatsu, N | 1 |
| Sato, K | 1 |
| Yamamoto, M | 2 |
| Maruo, K | 1 |
| Ishizu, T | 1 |
| Kawakami, Y | 1 |
| Ieda, M | 1 |
| Dorey, TW | 1 |
| Liu, Y | 1 |
| Jansen, HJ | 1 |
| Bohne, LJ | 1 |
| Mackasey, M | 1 |
| Atkinson, L | 1 |
| Prasai, S | 1 |
| Belke, DD | 1 |
| Fatehi-Hassanabad, A | 1 |
| Fedak, PWM | 1 |
| Rose, RA | 1 |
| McElhanon, KE | 1 |
| Huff, TC | 1 |
| Hirenallur-Shanthappa, D | 1 |
| Miller, RA | 1 |
| Christoforou, N | 1 |
| Nakamaru, R | 1 |
| Okada, M | 1 |
| Tanaka, N | 1 |
| Tanaka, K | 1 |
| Ninomiya, Y | 1 |
| Hirao, Y | 1 |
| Oka, T | 1 |
| Inoue, H | 2 |
| Takayasu, K | 1 |
| Koyama, Y | 2 |
| Okamura, A | 3 |
| Iwakura, K | 3 |
| Rakugi, H | 1 |
| Sakata, Y | 1 |
| Fujii, K | 3 |
| Inoue, K | 3 |
| Bai, J | 1 |
| Lu, Y | 1 |
| Zhang, H | 1 |
| Matsumoto, H | 1 |
| Tagahara, K | 1 |
| Hosono, H | 1 |
| Miyamoto, S | 1 |
| Uno, H | 1 |
| Kurokawa, H | 1 |
| Tokuda, K | 1 |
| Okuya, Y | 1 |
| Park, JY | 1 |
| Garg, A | 1 |
| Moussa, I | 1 |
| Badin, A | 1 |
| Hu, J | 1 |
| Wang, X | 1 |
| Cui, X | 1 |
| Kuang, W | 1 |
| Li, D | 1 |
| Wang, J | 1 |
| Velagic, V | 1 |
| Ströker, E | 1 |
| de Asmundis, C | 1 |
| Mugnai, G | 1 |
| Iacopino, S | 1 |
| de Regibus, V | 1 |
| Abugattas, JP | 1 |
| Coutiño, HE | 1 |
| Takarada, K | 1 |
| Choudhury, R | 1 |
| Paparella, G | 1 |
| De Greef, Y | 1 |
| Brugada, P | 2 |
| Chierchia, GB | 1 |
| Kanda, T | 1 |
| Masuda, M | 1 |
| Fujita, M | 1 |
| Iida, O | 1 |
| Okamoto, S | 1 |
| Ishihara, T | 1 |
| Nanto, K | 1 |
| Sunaga, A | 1 |
| Tsujimura, T | 1 |
| Matsuda, Y | 1 |
| Ohashi, T | 1 |
| Uematsu, M | 1 |
| Shiferaw, Y | 1 |
| Aistrup, GL | 1 |
| Wasserstrom, JA | 1 |
| AlTurki, A | 1 |
| Marshall, HJ | 1 |
| Proietti, R | 1 |
| Tutuianu, C | 2 |
| Pap, R | 2 |
| Riesz, T | 1 |
| Bencsik, G | 2 |
| Makai, A | 1 |
| Saghy, L | 2 |
| Kim, JH | 1 |
| Lee, SH | 2 |
| Park, SJ | 1 |
| Park, KM | 1 |
| On, YK | 1 |
| Kim, JS | 1 |
| Chang, CJ | 2 |
| Li, SJ | 1 |
| Chen, YC | 7 |
| Huang, SY | 1 |
| Chen, SA | 11 |
| Chen, YJ | 8 |
| Zhang, MX | 1 |
| Zheng, JK | 1 |
| Wang, WW | 1 |
| Kong, FQ | 1 |
| Wu, XX | 1 |
| Jiang, JK | 1 |
| Pan, JX | 1 |
| Lim, HS | 1 |
| Jaïs, P | 2 |
| Elayi, CS | 2 |
| Di Biase, L | 4 |
| Bai, R | 3 |
| Burkhardt, JD | 3 |
| Mohanty, P | 3 |
| Santangeli, P | 4 |
| Sanchez, J | 2 |
| Hongo, R | 3 |
| Gallinghouse, GJ | 2 |
| Horton, R | 3 |
| Bailey, S | 2 |
| Beheiry, S | 3 |
| Natale, A | 6 |
| Anter, E | 1 |
| Contreras-Valdes, FM | 1 |
| Shvilkin, A | 1 |
| Tschabrunn, CM | 1 |
| Josephson, ME | 1 |
| Yagishita, A | 1 |
| Yamauchi, Y | 1 |
| Obayashi, T | 1 |
| Hirao, K | 3 |
| Cheng, H | 1 |
| Dai, YY | 1 |
| Jiang, RH | 1 |
| Liu, Q | 1 |
| Sun, YX | 1 |
| Lin, JW | 1 |
| Zhang, ZW | 1 |
| Chen, SQ | 1 |
| Zhu, J | 1 |
| Sheng, X | 1 |
| Jiang, CY | 1 |
| Mohanty, S | 1 |
| Trivedi, C | 1 |
| Gallinghouse, JG | 1 |
| Sanchez, JE | 1 |
| Hranitzky, PM | 1 |
| Zagrodzky, J | 2 |
| Al-Ahmad, A | 1 |
| Pelargonio, G | 1 |
| Lakkireddy, D | 1 |
| Reddy, M | 1 |
| Forleo, G | 1 |
| Rossillo, A | 2 |
| Themistoclakis, S | 1 |
| Casella, M | 1 |
| Dello Russo, A | 1 |
| Tondo, C | 2 |
| Hasebe, H | 1 |
| Yoshida, K | 2 |
| Iida, M | 1 |
| Hatano, N | 1 |
| Muramatsu, T | 1 |
| Aonuma, K | 1 |
| Ghanbari, H | 1 |
| Jani, R | 1 |
| Hussain-Amin, A | 1 |
| Al-Assad, W | 1 |
| Huether, E | 1 |
| Ansari, S | 1 |
| Jongnarangsin, K | 3 |
| Crawford, T | 3 |
| Latchamsetty, R | 1 |
| Bogun, F | 4 |
| Morady, F | 4 |
| Oral, H | 3 |
| Chugh, A | 3 |
| Traykov, V | 1 |
| Klausz, G | 1 |
| Sugimura, S | 1 |
| Kurita, T | 1 |
| Kaitani, K | 1 |
| Yasuoka, R | 1 |
| Miyazaki, S | 1 |
| Lee, HC | 1 |
| Lin, HT | 1 |
| Ke, LY | 1 |
| Wei, C | 1 |
| Hsiao, YL | 1 |
| Chu, CS | 1 |
| Lai, WT | 1 |
| Shin, SJ | 1 |
| Chen, CH | 1 |
| Sheu, SH | 1 |
| Wu, BN | 1 |
| Kim, TH | 1 |
| Lee, JS | 1 |
| Park, J | 1 |
| Park, JK | 1 |
| Uhm, JS | 1 |
| Joung, B | 4 |
| Lee, MH | 2 |
| Pak, HN | 3 |
| Cheng, CC | 2 |
| Kao, YH | 1 |
| He, Z | 1 |
| Sun, C | 1 |
| Xu, Y | 1 |
| Cheng, D | 1 |
| Frommeyer, G | 2 |
| Sterneberg, M | 1 |
| Dechering, DG | 1 |
| Kaese, S | 2 |
| Bögeholz, N | 1 |
| Pott, C | 2 |
| Fehr, M | 1 |
| Bogossian, H | 1 |
| Milberg, P | 2 |
| Eckardt, L | 2 |
| Benson, DW | 1 |
| Cohen, MI | 1 |
| Lai, YJ | 1 |
| Huang, EY | 1 |
| Yeh, HI | 3 |
| Chen, YL | 1 |
| Lin, JJ | 1 |
| Lin, CI | 5 |
| Valles, E | 1 |
| Fan, R | 1 |
| Roux, JF | 1 |
| Liu, CF | 1 |
| Harding, JD | 1 |
| Dhruvakumar, S | 1 |
| Hutchinson, MD | 2 |
| Riley, M | 1 |
| Bala, R | 2 |
| Garcia, FC | 1 |
| Lin, D | 3 |
| Dixit, S | 4 |
| Callans, DJ | 5 |
| Gerstenfeld, EP | 6 |
| Marchlinski, FE | 5 |
| Furukawa, T | 1 |
| Horikawa-Tanami, T | 1 |
| Hachiya, H | 2 |
| Isobe, M | 2 |
| Sicouri, S | 2 |
| Belardinelli, L | 1 |
| Carlsson, L | 1 |
| Antzelevitch, C | 3 |
| Murray, KT | 1 |
| Yamazaki, M | 1 |
| Vaquero, LM | 1 |
| Hou, L | 1 |
| Campbell, K | 1 |
| Zlochiver, S | 1 |
| Klos, M | 1 |
| Mironov, S | 1 |
| Berenfeld, O | 1 |
| Honjo, H | 2 |
| Kodama, I | 2 |
| Jalife, J | 1 |
| Kalifa, J | 1 |
| Good, E | 2 |
| Ebinger, M | 1 |
| Pelosi, F | 2 |
| Lin, SF | 3 |
| Chen, Z | 1 |
| Antoun, PS | 1 |
| Maruyama, M | 2 |
| Han, S | 2 |
| Piccirillo, G | 1 |
| Stucky, M | 1 |
| Zipes, DP | 2 |
| Chen, PS | 6 |
| Das, MK | 1 |
| Kurotobi, T | 2 |
| Kimura, R | 1 |
| Tosyoshima, Y | 1 |
| Ito, N | 1 |
| Nof, E | 1 |
| Burashnikov, A | 1 |
| Arias, MA | 1 |
| Puchol, A | 1 |
| Castellanos, E | 1 |
| Rodríguez-Padial, L | 1 |
| Scanavacca, M | 1 |
| Sosa, E | 1 |
| Hwang, C | 2 |
| Fedorov, VV | 3 |
| Chang, R | 1 |
| Glukhov, AV | 2 |
| Kostecki, G | 1 |
| Janks, D | 1 |
| Schuessler, RB | 1 |
| Efimov, IR | 1 |
| Tsai, WC | 1 |
| Lin, YK | 3 |
| Datino, T | 1 |
| Macle, L | 1 |
| Chartier, D | 1 |
| Comtois, P | 1 |
| Khairy, P | 1 |
| Guerra, PG | 1 |
| Fernandez-Aviles, F | 2 |
| Nattel, S | 1 |
| Lazzara, R | 2 |
| Hwang, HJ | 1 |
| Shen, C | 1 |
| Pourrier, M | 1 |
| Gibson, JK | 1 |
| Lynch, JJ | 1 |
| O'Neill, DK | 1 |
| Aizer, A | 1 |
| Linton, P | 1 |
| Bloom, M | 1 |
| Rose, E | 1 |
| Chinitz, L | 1 |
| Lugenbiel, P | 1 |
| Thomas, D | 1 |
| Kelemen, K | 1 |
| Trappe, K | 1 |
| Bikou, O | 1 |
| Schweizer, PA | 1 |
| Voss, F | 1 |
| Becker, R | 1 |
| Katus, HA | 1 |
| Bauer, A | 1 |
| Viles-Gonzalez, JF | 1 |
| Miller, MA | 1 |
| d'Avila, A | 1 |
| Gemma, LW | 1 |
| Steinberg, LA | 1 |
| Prystowsky, EN | 1 |
| Padanilam, BJ | 1 |
| Chen, JH | 1 |
| Shetty, AK | 1 |
| Linton, NW | 1 |
| Krummen, DE | 1 |
| Bayer, JD | 1 |
| Ho, J | 1 |
| Smetak, MR | 1 |
| Clopton, P | 1 |
| Trayanova, NA | 1 |
| Narayan, SM | 1 |
| González de la Fuente, M | 1 |
| Barana, A | 1 |
| Gómez, R | 1 |
| Amorós, I | 1 |
| Dolz-Gaitón, P | 1 |
| Sacristán, S | 1 |
| Atienza, F | 1 |
| Pita, A | 1 |
| Pinto, Á | 1 |
| Caballero, R | 1 |
| Tamargo, J | 1 |
| Delpón, E | 1 |
| Schmidt, M | 1 |
| Clauß, C | 1 |
| Stypmann, J | 1 |
| Leong-Sit, P | 1 |
| Robinson, M | 1 |
| Zado, ES | 1 |
| Garcia, F | 1 |
| Riley, MP | 1 |
| Cooper, J | 1 |
| Arora, R | 1 |
| Verheule, S | 1 |
| Scott, L | 1 |
| Navarrete, A | 1 |
| Katari, V | 1 |
| Wilson, E | 1 |
| Vaz, D | 1 |
| Olgin, JE | 1 |
| Boyett, MR | 1 |
| Niwa, R | 1 |
| Inada, S | 1 |
| Mitsui, K | 1 |
| Horiuchi, T | 1 |
| Shibata, N | 1 |
| Kamiya, K | 1 |
| Kuo, JY | 1 |
| Tai, CT | 3 |
| Tsao, HM | 1 |
| Hsieh, MH | 2 |
| Tsai, CF | 2 |
| Lin, WS | 1 |
| Ding, YA | 1 |
| Hou, CJ | 1 |
| Tsai, CH | 1 |
| Hegbom, F | 2 |
| Orning, OM | 2 |
| Gjesdal, K | 2 |
| SCHWARTZ, LS | 2 |
| SCHWARTZ, SP | 2 |
| HEINECKER, R | 2 |
| GROSSE-BROCKHOFF, F | 1 |
| MATTHEWS, RJ | 1 |
| Sanders, P | 2 |
| Morton, JB | 1 |
| Kistler, PM | 1 |
| Vohra, JK | 1 |
| Kalman, JM | 1 |
| Sparks, PB | 1 |
| Khan, IA | 1 |
| Hsu, LF | 1 |
| Keane, D | 1 |
| Wharton, JM | 2 |
| Deisenhofer, I | 1 |
| Hocini, M | 1 |
| Shah, DC | 1 |
| Scavée, C | 1 |
| Weerasooriya, R | 1 |
| Clémenty, J | 1 |
| Haïssaguerre, M | 1 |
| Sharifov, OF | 2 |
| Beloshapko, GG | 2 |
| Yushmanova, AV | 1 |
| Rosenshtraukh, LV | 1 |
| Nakagawa, H | 1 |
| Aoyama, H | 1 |
| Beckman, KJ | 1 |
| Po, SS | 1 |
| Wu, R | 1 |
| Lockwood, D | 1 |
| Spector, P | 1 |
| Calame, JD | 1 |
| Lustgarten, DL | 1 |
| Herring, L | 1 |
| Hasdemir, C | 1 |
| Singh, D | 1 |
| Jackman, WM | 1 |
| Lo, HM | 1 |
| Lin, FY | 1 |
| Tseng, YZ | 1 |
| Ren, JF | 1 |
| Kiss, O | 1 |
| Zima, E | 1 |
| Soós, P | 1 |
| Kékesi, V | 1 |
| Juhász-Nagy, A | 1 |
| Merkely, B | 1 |
| Beldner, S | 1 |
| Marchlinski, F | 1 |
| Nanthakumar, K | 1 |
| Lau, YR | 1 |
| Plumb, VJ | 1 |
| Epstein, AE | 1 |
| Kay, GN | 1 |
| Heldal, M | 1 |
| Christ, T | 1 |
| Boknik, P | 1 |
| Wöhrl, S | 1 |
| Wettwer, E | 1 |
| Graf, EM | 1 |
| Bosch, RF | 1 |
| Knaut, M | 1 |
| Schmitz, W | 1 |
| Ravens, U | 1 |
| Dobrev, D | 1 |
| Mainardi, LT | 2 |
| Corino, VD | 2 |
| Lombardi, L | 1 |
| Mantica, M | 2 |
| Lombardi, F | 2 |
| Cerutti, S | 1 |
| Lazar, S | 1 |
| Marrouche, N | 1 |
| Wazni, OM | 1 |
| Martin, DO | 1 |
| Saliba, W | 1 |
| Erciyes, D | 1 |
| Schweikert, R | 1 |
| Khaykin, Y | 1 |
| Burkhardt, D | 1 |
| Bhargava, M | 1 |
| Verma, A | 1 |
| Abdul-Karim, A | 1 |
| Temple, J | 1 |
| Frias, P | 1 |
| Rottman, J | 1 |
| Yang, T | 1 |
| Wu, Y | 1 |
| Verheijck, EE | 1 |
| Zhang, W | 1 |
| Siprachanh, C | 1 |
| Kanki, H | 1 |
| Atkinson, JB | 1 |
| King, P | 1 |
| Anderson, ME | 1 |
| Kupershmidt, S | 1 |
| Roden, DM | 1 |
| Di Scala, E | 1 |
| Findlay, I | 1 |
| Rose, S | 1 |
| Aupart, M | 1 |
| Argibay, J | 1 |
| Cosnay, P | 1 |
| Bozon, V | 1 |
| Miyauchi, Y | 1 |
| Hayashi, H | 1 |
| Miyauchi, M | 1 |
| Okuyama, Y | 1 |
| Mandel, WJ | 2 |
| Karagueuzian, HS | 3 |
| Li, J | 1 |
| Wang, L | 1 |
| Redpath, CJ | 1 |
| Rankin, AC | 2 |
| Kane, KA | 2 |
| Workman, AJ | 2 |
| Isa-Param, R | 1 |
| Pérez-Castellano, N | 1 |
| Villacastín, J | 1 |
| Moreno, J | 1 |
| Salinas, J | 1 |
| Alonso, R | 1 |
| Ruiz, E | 1 |
| Doblado, M | 1 |
| Morales, R | 1 |
| Macaya, C | 1 |
| Ito, H | 1 |
| Kawano, S | 1 |
| Date, M | 1 |
| Pau, D | 1 |
| Takahashi, A | 2 |
| Nagata, Y | 1 |
| Suzuki, K | 1 |
| Maeda, S | 1 |
| Kawabata, M | 1 |
| Iesaka, Y | 2 |
| Lo, LW | 1 |
| Wongcharoen, W | 1 |
| Brembilla-Perrot, B | 6 |
| Chometon, F | 1 |
| Groben, L | 1 |
| Ammar, S | 1 |
| Bertrand, J | 1 |
| Marcha, C | 1 |
| Cloez, JL | 1 |
| Tisserand, A | 1 |
| Huttin, O | 1 |
| Tatar, C | 1 |
| Duhoux, F | 1 |
| Yangni N'da, O | 1 |
| Beurrier, D | 3 |
| Terrier de Chaise, A | 1 |
| Zhang, N | 1 |
| Abbas, M | 1 |
| Cedano, J | 1 |
| Marçon, F | 1 |
| Sampson, KJ | 1 |
| Terrenoire, C | 1 |
| Cervantes, DO | 1 |
| Kaba, RA | 1 |
| Peters, NS | 1 |
| Kass, RS | 1 |
| Kovarik, JM | 1 |
| Riviere, GJ | 1 |
| Neddermann, D | 1 |
| Maton, S | 1 |
| Hunt, TL | 1 |
| Schmouder, RL | 1 |
| Park, MY | 1 |
| Shin, SH | 1 |
| Oh, WJ | 1 |
| Lim, HE | 1 |
| Lim, DS | 1 |
| Kim, YH | 2 |
| Ro, YM | 1 |
| Shim, WJ | 1 |
| Frederick, M | 1 |
| Gadeela, N | 1 |
| Wimmer, A | 1 |
| Dey, S | 1 |
| Sarrazin, JF | 1 |
| Kuhne, M | 1 |
| Chalfoun, N | 1 |
| Wells, D | 1 |
| Jacobson, J | 1 |
| Passman, R | 1 |
| Tschirdewahn, B | 1 |
| Knorpp, K | 1 |
| Heinrich, F | 1 |
| Schütterle, G | 1 |
| Wellens, HJ | 1 |
| Abdollah, H | 1 |
| German, LD | 1 |
| Gallagher, JJ | 1 |
| Broughton, A | 1 |
| Guarnieri, T | 1 |
| Trantham, JL | 1 |
| Terrier de La Chaise, A | 2 |
| Shimizu, A | 1 |
| Fukatani, M | 1 |
| Tanigawa, M | 1 |
| Kaibara, M | 1 |
| Konoe, A | 1 |
| Isomoto, S | 1 |
| Centurion, OA | 1 |
| Yano, K | 1 |
| Hashiba, K | 1 |
| Brignole, M | 1 |
| Gianfranchi, L | 1 |
| Menozzi, C | 1 |
| Raviele, A | 1 |
| Oddone, D | 1 |
| Lolli, G | 1 |
| Bottoni, N | 1 |
| Laub, GW | 1 |
| Muralidharan, S | 1 |
| Janeira, L | 1 |
| Moore, RA | 1 |
| Clancy, R | 1 |
| Adkins, MS | 1 |
| Fernandez, J | 1 |
| Anderson, WA | 1 |
| McGrath, LB | 1 |
| Chiang, CE | 1 |
| Chiou, CW | 1 |
| Ueng, KC | 1 |
| Wen, ZC | 1 |
| Chang, MS | 4 |
| Strickberger, SA | 1 |
| Weiss, R | 1 |
| Daoud, EG | 1 |
| Goyal, R | 1 |
| Man, KC | 1 |
| Markowitz, SM | 1 |
| Stein, KM | 1 |
| Lerman, BB | 1 |
| Lok, NS | 1 |
| Lau, CP | 1 |
| Shepard, RK | 1 |
| Stambler, BS | 1 |
| Wood, MA | 1 |
| Gilligan, DM | 1 |
| Ellenbogen, KA | 1 |
| Mäki, T | 1 |
| Toivonen, L | 1 |
| Koskinen, P | 1 |
| Näveri, H | 1 |
| Härkönen, M | 1 |
| Leinonen, H | 1 |
| Barold, HS | 1 |
| Shander, G | 1 |
| Tomassoni, G | 1 |
| Simons, GR | 1 |
| Piano, MR | 1 |
| Rosenblum, C | 1 |
| Solaro, RJ | 1 |
| Schwertz, D | 1 |
| Biffi, M | 1 |
| Boriani, G | 1 |
| Bronzetti, G | 1 |
| Capucci, A | 1 |
| Branzi, A | 2 |
| Magnani, B | 1 |
| Doshi, RN | 1 |
| Wu, TJ | 1 |
| Yashima, M | 1 |
| Ong, JJ | 1 |
| Cao, JM | 1 |
| Yashar, P | 1 |
| Fishbein, MC | 1 |
| Van Wagoner, DR | 1 |
| Pond, AL | 1 |
| Lamorgese, M | 1 |
| Rossie, SS | 1 |
| McCarthy, PM | 1 |
| Nerbonne, JM | 1 |
| Jahangiri, A | 1 |
| Leifert, WR | 1 |
| Patten, GS | 1 |
| McMurchie, EJ | 1 |
| Lee, PC | 1 |
| Houriez, P | 1 |
| Preiss, JP | 1 |
| Louis, P | 1 |
| Claudon, O | 1 |
| Skasa, M | 1 |
| Jüngling, E | 1 |
| Picht, E | 1 |
| Schöndube, F | 1 |
| Lückhoff, A | 1 |
| Chan, P | 1 |
| Schotten, U | 1 |
| Greiser, M | 1 |
| Benke, D | 1 |
| Buerkel, K | 1 |
| Ehrenteidt, B | 1 |
| Stellbrink, C | 1 |
| Vazquez-Jimenez, JF | 1 |
| Schoendube, F | 1 |
| Hanrath, P | 1 |
| Allessie, M | 1 |
| Iushmanova, AV | 1 |
| Rozenshtraukh, LV | 1 |
| Katritsis, D | 1 |
| Giazitzoglou, E | 1 |
| Korovesis, S | 1 |
| Paxinos, G | 1 |
| Anagnostopoulos, CE | 1 |
| Camm, AJ | 1 |
| Date, T | 1 |
| Miyazaki, H | 1 |
| Yamane, T | 1 |
| Noma, K | 1 |
| Nuruiki, N | 1 |
| Ishikawa, S | 1 |
| Kanae, K | 1 |
| Mochizuki, S | 1 |
| Bartsch, W | 1 |
| Sponer, G | 1 |
| Dietmann, K | 1 |
| Lubbe, WF | 1 |
| Hilwig, RW | 1 |
| Scheinman, MM | 1 |
| Strauss, HC | 1 |
| Abbott, JA | 1 |
| Khalsa, A | 1 |
| Olsson, SB | 1 |
| Gill, MA | 1 |
| Miscia, VF | 1 |
| Gourley, DR | 1 |
| Kikawada, R | 1 |
| Noro, C | 1 |
| Tsuyusaki, T | 1 |
| Muramatsu, J | 1 |
| Kakubari, Y | 1 |
| Billette, J | 1 |
| Roberge, FA | 1 |
| Nadeau, RA | 2 |
| Bleifeld, W | 2 |
| Porlier, GA | 1 |
| Elharrar, V | 1 |
| Gauthier, P | 1 |
| Madrid, AH | 1 |
| Moro, C | 1 |
| Maŕin Huerta, EM | 1 |
| Novo, L | 1 |
| Mestre, JL | 1 |
| Chimienti, M | 1 |
| Li Bergolis, M | 1 |
| Moizi, M | 1 |
| Klersy, C | 1 |
| Negroni, MS | 1 |
| Salerno, JA | 1 |
| Walsh, CA | 1 |
| Singer, LP | 1 |
| Mercando, AD | 1 |
| Furman, S | 1 |
| Ghawi, R | 1 |
| Dechaux, JP | 1 |
| Pagé, PL | 1 |
| Hassanalizadeh, H | 1 |
| Cardinal, R | 1 |
| Rea, RF | 1 |
| Biaggioni, I | 1 |
| Robertson, RM | 1 |
| Haile, V | 1 |
| Robertson, D | 1 |
| David, D | 1 |
| Lang, RM | 1 |
| Neumann, A | 1 |
| Borow, KM | 1 |
| Akselrod, S | 1 |
| Mor-Avi, V | 1 |
| Jordan, JL | 1 |
| Sugi, K | 1 |
| Ohta, M | 1 |
| Gang, E | 1 |
| Peter, T | 1 |
| Swerdlow, CD | 1 |
| Peterson, J | 1 |
| Liem, LB | 1 |
| Szabo, TS | 1 |
| Klein, GJ | 1 |
| Sharma, AD | 1 |
| Yee, R | 1 |
| Milstein, S | 1 |
| Bump, TE | 1 |
| Ripley, KL | 1 |
| Guezennec, A | 1 |
| Arzbaecher, R | 1 |
| Fujiki, A | 1 |
| Yoshida, S | 1 |
| Tani, M | 1 |
| Sasayama, S | 1 |
| Belic, N | 1 |
| Talano, JV | 1 |
| Sterz, H | 1 |
| Rios, JC | 1 |
| Dziok, CA | 1 |
| Ali, NA | 1 |
| Goodwin, JF | 1 |
| Gettes, LS | 1 |
| Robinson, SJ | 1 |
| Amor, H | 1 |
| Dienstl, F | 1 |
| Judmaier, G | 1 |
| Schwingshackl, H | 1 |
| Fuccella, LM | 1 |
| Motté, G | 1 |
| Fouchard, J | 1 |
| Hashimoto, K | 1 |
| Suzuki, Y | 1 |
| Chiba, S | 1 |
| Raynaud, R | 1 |
| Brochier, M | 1 |
| Morand, P | 1 |
| Raynaud, P | 1 |
| Fauchier, JP | 1 |
| Raper, C | 1 |
| Jowett, A | 1 |
| Obel, IW | 1 |
| Kerber, RE | 1 |
| Goldman, RH | 1 |
| Gianelly, RE | 1 |
| Harrison, DC | 2 |
| Lloyd, TC | 1 |
| Alderman, EL | 1 |
| Sanders, W | 1 |
| Brown, BW | 1 |
| Ferrer, MI | 1 |
| Kastor, JA | 1 |
| May, KL | 1 |
| Morton, EV | 1 |
| Roberts, LN | 1 |
| Montessori, G | 1 |
| Patterson, JG | 1 |
| Quarry-Pigott, V | 1 |
| Chirife, R | 1 |
| Spodick, DH | 1 |
| Starmer, CF | 1 |
| McHale, PA | 1 |
| Cobb, FR | 1 |
| Greenfield, JC | 1 |
| Bleecker, ER | 1 |
| Engel, BT | 1 |
| Honzíková, N | 1 |
| Fiser, B | 1 |
| Semrád, B | 1 |
| Rokseth, R | 1 |
| Hatle, L | 1 |
| Merx, W | 1 |
| Effert, S | 1 |
| Damato, AN | 2 |
| Lau, SH | 2 |
| Lemberg, L | 1 |
| Castellanos, A | 1 |
| Arcebal, AG | 1 |
| Iyengar, RN | 1 |
| Marriott, HJ | 1 |
| Leon, L | 1 |
| Cabrol, A | 1 |
| Cabrol, C | 1 |
| Luciani, J | 1 |
| Chapelle, M | 1 |
| Guiraudon, G | 1 |
| Cohen, HE | 1 |
| Meltzer, LE | 1 |
| Lattimer, G | 1 |
| Linares, H | 1 |
| Agrin, R | 1 |
| Eraut, D | 1 |
| Shaw, DB | 1 |
| Mason, DT | 1 |
| Gabe, IT | 1 |
| Mills, CJ | 1 |
| Gault, JH | 1 |
| Ross, J | 1 |
| Braunwald, E | 1 |
| Shillingford, JP | 1 |
| Criscitiello, MG | 1 |
| O'Rourke, RA | 1 |
| Schröder, R | 1 |
| Dissmann, W | 1 |
| Buschmann, HJ | 1 |
| Schneider, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation[NCT01173809] | Phase 3 | 176 participants (Anticipated) | Interventional | 2010-10-31 | Completed | ||
| [NCT02138695] | 3,100 participants (Anticipated) | Observational | 2014-05-31 | Recruiting | |||
| Study to Measure BIS and Awareness in Patients Receiving Isoproterenol During Catheter Ablation for Atrial Fibrillation[NCT01377636] | 20 participants (Actual) | Interventional | 2009-08-31 | Completed | |||
| First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment[NCT04037397] | Phase 3 | 120 participants (Anticipated) | Interventional | 2019-09-24 | Active, not recruiting | ||
| A Pilot Study to Investigate the Efficacy and Safety of Dexmedetomidine and Fentanyl Versus Midazolam and Remifentanil for Sedation in Patients Undergoing Ablation Procedures for Treatment of a Tachyarrhythmia[NCT03451227] | 6 participants (Actual) | Interventional | 2017-12-01 | Terminated (stopped due to Unable to recruit eligible participants) | |||
| Multi-center, Randomized, Controlled Trial to Compare Feasibility, Safety and Efficacy of Zero-Fluoroscopic Navigation With Conventional Fluoroscopic Navigation for the Ablation of Right Atrial Arrhythmias[NCT03151278] | 212 participants (Actual) | Interventional | 2011-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The BIS scale ranges from 0 to 100. The individual's baseline BIS was measured continuously and was maintained in an anesthetic steady state with minimum variance prior to isoproterenol. A deviation from the mean in excess of 3 points (2 STD) was defined categorically as a positive response and was counted dichotomously.The difference between Pre-BIS and Post-BIS was calculated. (NCT01377636)
Timeframe: Within 20 minutes of starting isoproterenol infusion
| Intervention | units on a scale (Mean) |
|---|---|
| Pre and Post Isoproterenol Infusion | 24.6 |
The (ST) segment on the EKG was monitored for changes suggestive of demand ischemia. An observable EKG change compared to baseline was defined categorically as a positive response and was counted dichotomously. (NCT01377636)
Timeframe: Within 20 minutes of starting isoproterenol infusion
| Intervention | participants (Number) |
|---|---|
| Pre and Post Isoproterenol Infusion | 2 |
"Increasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. Ability to follow verbal commands before and after isoproterenol infusion was assessed by asking subjects to squeeze my hands." (NCT01377636)
Timeframe: Within 20 minutes of starting isoproterenol infusion
| Intervention | participants (Number) |
|---|---|
| Isoproterenol, BIS, Forearm Test | 10 |
Increasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. Specific pre-determined test words were spoken to the subject during administration of isoproterenol. After anesthesia, patients were tested for possible recall of those specific words. If no words were recalled, the result was categorically defined as amnesia. (NCT01377636)
Timeframe: Within one hour of completing anesthesia
| Intervention | participants (Number) |
|---|---|
| Isoproterenol, BIS, Forearm Test | 20 |
Increasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. BIS levels were measured continuously before and after isoproterenol administration. Number of participants with increase in BIS reading during anesthetic steady state are reported below. The BIS scale ranges from 0 to 100. The individual's baseline BIS was measured continuously and was maintained in an anesthetic steady state with minimum variance prior to isoproterenol. A deviation from the mean in excess of 3 points (2 STD) was defined categorically as a positive response and was counted dichotomously. (NCT01377636)
Timeframe: During time of Electrophysiology (EP) studies.
| Intervention | participants (Number) |
|---|---|
| Pre and Post Isoproterenol Infusion | 19 |
Non-Invasive Blood Pressure (NIBP) is measured routinely as part of an anesthetic. Pre- and Post Blood Pressures where noted. An increase or decrease of 10 percent or more was defined as a significant change in systolic blood pressure. (NCT01377636)
Timeframe: Within 20 minutes of starting isoproterenol infusion
| Intervention | participants (Number) |
|---|---|
| Pre and Post Isoproterenol Infusion | 13 |
Increasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation after return to sinus rhythm. If a non-sinus arrhythmia resulted from the infusion, the arrhythmia was defined categorically as a positive response and was counted dichotomously. (NCT01377636)
Timeframe: Within 20 minutes of start of isoproterenol
| Intervention | participants (Number) |
|---|---|
| Pre and Post Isoproterenol Infusion | 4 |
Heart rate measured by standard EKG monitor during anesthesia. Pre- and Post Heart rates where noted. An increase of 8 percent or more was defined as a significant change in heart rate. (NCT01377636)
Timeframe: Within 20 minutes of starting isoproterenol infusion
| Intervention | participants (Number) |
|---|---|
| Pre and Post Isoproterenol Infusion | 18 |
Increasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. Patients under steady state total venous anesthesia (TIVA) with propofol and remifentanil infusions with BIS around 50 normally do not move even in the absence of neuromuscular blockade. Spontaneous movement appearing like restlessness during sleep is unusual. Several patients under anesthesia after isoproterenol appear to wake up and move spontaneously. (NCT01377636)
Timeframe: Within 20 minutes of starting isoproterenol infusion
| Intervention | participants (Number) |
|---|---|
| Isoproterenol, BIS, Forearm Test | 12 |
25 reviews available for isoproterenol and Atrial Fibrillation
| Article | Year |
|---|---|
Isoproterenol-Assisted Differentiation Between Sludge and Organized Thrombus to Guide Left Atrial Appendage Occlusion.
Topics: Atrial Appendage; Atrial Fibrillation; Heart Diseases; Humans; Isoproterenol; Retrospective Studies; | 2023 |
Targeting nonpulmonary vein triggers during atrial fibrillation ablation: is the game worth the candle?
Topics: Adenosine; Adrenergic beta-Agonists; Anti-Arrhythmia Agents; Atrial Appendage; Atrial Fibrillation; | 2018 |
Wolff-Parkinson-White syndrome: lessons learnt and lessons remaining.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Death, Sudden, Cardiac; E | 2017 |
How to ablate long-standing persistent atrial fibrillation?
Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Cardiotonic Agents; C | 2013 |
How to ablate long-standing persistent atrial fibrillation?
Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Cardiotonic Agents; C | 2013 |
How to ablate long-standing persistent atrial fibrillation?
Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Cardiotonic Agents; C | 2013 |
How to ablate long-standing persistent atrial fibrillation?
Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Cardiotonic Agents; C | 2013 |
THE EFFECTS OF DIGITALIS BODIES ON PATIENTS WITH HEART BLOCK AND CONGESTIVE HEART FAILURE.
Topics: Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Digitalis; Digitalis Glycosides; D | 1964 |
[MEDICAL MEASURES IN HEART FIBRILLATION AND HEART ARREST].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Brugada Syndrome; Cardiac Conduction System Disease; Drug | 1964 |
Atrial stunning: basics and clinical considerations.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Function; Atrial Functi | 2003 |
Ablation of atrial fibrillation: localizing triggers, mapping systems and ablation techniques.
Topics: Adrenergic beta-Agonists; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Heart Atria; | 2004 |
Persistent pulmonary vein isolation: the elusive goal of atrial fibrillation ablation.
Topics: Adenosine Triphosphate; Adult; Atrial Fibrillation; Cardiotonic Agents; Catheter Ablation; Drug Ther | 2007 |
Clinical usefulness of the beta-adrenergic antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Anx | 1978 |
Cardiac arrhythmias in the dog: detection and treatment.
Topics: Animals; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Bradycardia; Cardiac Complexe | 1976 |
Electrophysiologic testing for patients with sinus node dysfunction.
Topics: Aged; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Bradycardia; Cardiac P | 1979 |
The treatment of common cardiac arrhythmias.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atropine | 1976 |
[Significance of tachycardia induced by atrial stimulation in Wolff-Parkinson-White syndrome].
Topics: Atrial Fibrillation; Cardiac Pacing, Artificial; Heart Atria; Humans; Isoproterenol; Tachycardia; Wo | 1992 |
Digitalis-induced arrhythmias: recognition and management.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Cardiac Complexes, Premature; Digitalis Glycosi | 1970 |
Treatment of the cardiomyopathies.
Topics: Adrenergic beta-Antagonists; Alcoholism; Angina Pectoris; Anticoagulants; Atrial Fibrillation; Blood | 1973 |
Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillatio | 1970 |
Treatment of cardiac arrhythmias.
Topics: Adams-Stokes Syndrome; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 1964 |
The sick sinus syndrome.
Topics: Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Bradycardia; Death, Sudden; | 1973 |
Digitalis intoxication in patients with atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Catecholamines; Diagnosis, | 1973 |
[Sympathomimetics in the treatment of bronchospastic conditions].
Topics: Atrial Fibrillation; Bronchi; Bronchial Spasm; Coronary Disease; Humans; Isoproterenol; Metaproteren | 1974 |
Clinical value of the electrogram of the conduction system.
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Atropine; Bundle-Branch Block; Cardiac Catheterization; C | 1970 |
The treatment of arrhythmias following acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Bradycardia; Coronary Care Units; Digitalis Gly | 1971 |
Mechanisms of A-V block.
Topics: Action Potentials; Atrial Fibrillation; Atrial Flutter; Atropine; Digitalis Glycosides; Electric Sti | 1970 |
Management of cardiac dysrhythmias complicating acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atropine; Bradycardia; Bretylium Compound | 1968 |
21 trials available for isoproterenol and Atrial Fibrillation
| Article | Year |
|---|---|
Is adenosine useful for the identification of atrial fibrillation triggers?
Topics: Action Potentials; Adenosine; Adrenergic beta-Agonists; Aged; Atrial Fibrillation; Catheter Ablation | 2019 |
Administration of isoproterenol and adenosine to guide supplemental ablation after pulmonary vein antrum isolation.
Topics: Adenosine; Aged; Atrial Fibrillation; Drug Administration Schedule; Electrocardiography; Electrophys | 2013 |
Non-pulmonary vein foci induced before and after pulmonary vein isolation in patients undergoing ablation therapy for paroxysmal atrial fibrillation: incidence and clinical outcome.
Topics: Adenosine Triphosphate; Atrial Fibrillation; Cardiotonic Agents; Catheter Ablation; Female; Heart Co | 2014 |
Effect of periprocedural amiodarone on procedure outcome in patients with longstanding persistent atrial fibrillation undergoing extended pulmonary vein antrum isolation: results from a randomized study (SPECULATE).
Topics: Adrenergic beta-Agonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter A | 2015 |
Role of adenosine after antral pulmonary vein isolation of paroxysmal atrial fibrillation: A randomized controlled trial.
Topics: Adenosine; Aged; Atrial Fibrillation; Cardiovascular Agents; Catheter Ablation; Female; Humans; Intr | 2016 |
Blunted rate-dependent left atrial pressure response during isoproterenol infusion in atrial fibrillation patients with impaired left ventricular diastolic function: a comparison to pacing.
Topics: Atrial Fibrillation; Atrial Pressure; Cardiac Pacing, Artificial; Cardiotonic Agents; Catheter Ablat | 2015 |
Clinical value of noninducibility by high-dose isoproterenol versus rapid atrial pacing after catheter ablation of paroxysmal atrial fibrillation.
Topics: Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiotonic Agents; Catheter Ablation; Dose-Respons | 2010 |
Identifying the relationship between the non-PV triggers and the critical CFAE sites post-PVAI to curtail the extent of atrial ablation in longstanding persistent AF.
Topics: Adrenergic beta-Agonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Chi- | 2011 |
Isoproterenol infusion increases level of consciousness during catheter ablation of atrial fibrillation.
Topics: Adult; Aged; Anesthetics, Intravenous; Atrial Fibrillation; Catheter Ablation; Consciousness; Electr | 2012 |
Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy.
Topics: Adrenergic beta-Agonists; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiomyopathies; Chronic | 2003 |
Mechanisms underlying sustained firing from pulmonary veins: evidence from pacing maneuvers and pharmacological manipulation.
Topics: Adenosine; Atrial Fibrillation; Cardiac Pacing, Artificial; Female; Humans; Isoproterenol; Male; Mid | 2004 |
Effects of ablation, digitalis, and beta-blocker on dual atrioventricular nodal pathways and conduction during atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Atrioventricular Node; Catheter Ablation; Digitali | 2004 |
Marshall vein as arrhythmogenic source in patients with atrial fibrillation: correlation between its anatomy and electrophysiological findings.
Topics: Atrial Fibrillation; Biological Clocks; Body Surface Potential Mapping; Cardiotonic Agents; Coronary | 2006 |
Clinical implications of reconnection between the left atrium and isolated pulmonary veins provoked by adenosine triphosphate after extensive encircling pulmonary vein isolation.
Topics: Adenosine Triphosphate; Atrial Fibrillation; Cardiotonic Agents; Catheter Ablation; Drug Therapy, Co | 2007 |
A mechanistic study to assess whether isoproterenol can reverse the negative chronotropic effect of fingolimod.
Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Area Under Curve; Atrial Fibrillation; Bradyc | 2008 |
Inducibility of paroxysmal atrial fibrillation by isoproterenol and its relation to the mode of onset of atrial fibrillation.
Topics: Adrenergic beta-Agonists; Adult; Atrial Fibrillation; Dose-Response Relationship, Drug; Electrocardi | 2008 |
[Predictive value of induction of atrial flutter or fibrillation in paroxysmal junctional tachycardia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Cardiotonic Agents; | 2000 |
Epicardial foci of atrial arrhythmias apparently originating in the left pulmonary veins.
Topics: Adult; Aged; Atrial Fibrillation; Body Surface Potential Mapping; Catheter Ablation; Female; Heart C | 2002 |
Trasicor: review of the pharmacology and clinical results.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Animals; Arrhythmias, Cardiac | 1969 |
Clinical and experimental experience with 39089 BA (trasicor) as an anti-arrhythmic agent.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Adult; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; | 1969 |
Clinical value of the electrogram of the conduction system.
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Atropine; Bundle-Branch Block; Cardiac Catheterization; C | 1970 |
167 other studies available for isoproterenol and Atrial Fibrillation
| Article | Year |
|---|---|
Electrophysiological characteristics of atrial tachycardia recurrence: Relevance to catheter ablation strategies in adults with congenital heart disease.
Topics: Adrenergic beta-Agonists; Adult; Atrial Fibrillation; Catheter Ablation; Electrophysiologic Techniqu | 2022 |
Evaluation of arrhythmogenic foci using a novel automated detection algorithm and isoproterenol in persistent atrial fibrillation.
Topics: Algorithms; Atrial Fibrillation; Catheter Ablation; Humans; Isoproterenol; Pulmonary Veins; Recurren | 2022 |
Provocation and localization of atrial ectopy in patients with atrial septal defects.
Topics: Atrial Fibrillation; Cohort Studies; Electrocardiography, Ambulatory; Heart Septal Defects, Atrial; | 2022 |
Pinocembrin alleviates the susceptibility to atrial fibrillation in isoproterenol-induced rats.
Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Caspase 1; Collagen Type I; Connexins; Disease Mode | 2022 |
Isoproterenol loading transesophageal echocardiography in atrial fibrillation.
Topics: Aged; Atrial Appendage; Atrial Fibrillation; Echocardiography, Transesophageal; Female; Humans; Isop | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Association of isoproterenol infusion during catheter ablation of atrial fibrillation with outcomes: insights from the UC San Diego AF Ablation Registry.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Humans; Isoproterenol; Recurrence; R | 2023 |
Association of isoproterenol infusion during catheter ablation of atrial fibrillation with outcomes: insights from the UC San Diego AF Ablation Registry.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Humans; Isoproterenol; Recurrence; R | 2023 |
Association of isoproterenol infusion during catheter ablation of atrial fibrillation with outcomes: insights from the UC San Diego AF Ablation Registry.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Humans; Isoproterenol; Recurrence; R | 2023 |
Association of isoproterenol infusion during catheter ablation of atrial fibrillation with outcomes: insights from the UC San Diego AF Ablation Registry.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Humans; Isoproterenol; Recurrence; R | 2023 |
Stepwise Increase of Isoproterenol Bolus Dose Method for Differentiating Left Atrial Appendage Sludge From Thrombus.
Topics: Atrial Appendage; Atrial Fibrillation; Echocardiography, Transesophageal; Humans; Isoproterenol; Sew | 2023 |
Stepwise Increase of Isoproterenol Bolus Dose Method for Differentiating Left Atrial Appendage Sludge From Thrombus.
Topics: Atrial Appendage; Atrial Fibrillation; Echocardiography, Transesophageal; Humans; Isoproterenol; Sew | 2023 |
Stepwise Increase of Isoproterenol Bolus Dose Method for Differentiating Left Atrial Appendage Sludge From Thrombus.
Topics: Atrial Appendage; Atrial Fibrillation; Echocardiography, Transesophageal; Humans; Isoproterenol; Sew | 2023 |
Stepwise Increase of Isoproterenol Bolus Dose Method for Differentiating Left Atrial Appendage Sludge From Thrombus.
Topics: Atrial Appendage; Atrial Fibrillation; Echocardiography, Transesophageal; Humans; Isoproterenol; Sew | 2023 |
Mechanisms of Modulation of Adrenergic Regulation of Spontaneous Activity Rate and Atrial Myocardial Contractility in Early Postnatal Ontogeny in Rats.
Topics: Adrenergic Agents; Animals; Atrial Fibrillation; Isoproterenol; Neuropeptide Y; Rats; Receptors, Neu | 2023 |
Steady-state and transient effects of SK channel block and adrenergic stimulation to counteract acetylcholine-induced arrhythmogenic effects in the human atria: A computational study.
Topics: Acetylcholine; Action Potentials; Adrenergic Agents; Atrial Fibrillation; Heart Atria; Humans; Isopr | 2023 |
Efficacy of Low-Dose Isoproterenol Infusion for the Exclusion of a Left Atrial Appendage Thrombus in Patients With Dense Spontaneous Echo Contrast Caused by Atrial Fibrillation.
Topics: Atrial Appendage; Atrial Fibrillation; Echocardiography, Transesophageal; Heart Diseases; Humans; Is | 2023 |
Natriuretic Peptide Receptor B Protects Against Atrial Fibrillation by Controlling Atrial cAMP Via Phosphodiesterase 2.
Topics: Animals; Atrial Fibrillation; Heart Atria; Humans; Isoproterenol; Mice; Myocytes, Cardiac; Natriuret | 2023 |
Increased circulating progranulin is not sufficient to induce cardiac dysfunction or supraventricular arrhythmia.
Topics: Animals; Atrial Fibrillation; Electrocardiography; Heart Rate; Isoproterenol; Mice; Obesity; Progran | 2023 |
Outcomes After Atrial Fibrillation Ablation in Patients With Premature Atrial Contractions Originating From Non-Pulmonary Veins.
Topics: Adrenergic beta-Agonists; Aged; Atrial Fibrillation; Atrial Premature Complexes; Catheter Ablation; | 2019 |
In silico study of the effects of anti-arrhythmic drug treatment on sinoatrial node function for patients with atrial fibrillation.
Topics: Acetylcholine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Rate; Humans; Isoprote | 2020 |
Efficacy of isoproterenol in the evaluation of dormant conduction and arrhythmogenic foci identification in atrial fibrillation ablation.
Topics: Action Potentials; Adenosine; Adrenergic beta-Agonists; Aged; Atrial Fibrillation; Catheter Ablation | 2020 |
SK Channel Block and Adrenergic Stimulation Counteract Acetylcholine-Induced Arrhythmogenic Effects in Human Atria.
Topics: Acetylcholine; Adrenergic Agents; Atrial Fibrillation; Heart Atria; Humans; Isoproterenol | 2020 |
Coronary Artery Spasm During Catheter Ablation Caused by the Intravenous Infusion of Isoproterenol.
Topics: Atrial Fibrillation; Catheter Ablation; Coronary Vessels; Humans; Infusions, Intravenous; Isoprotere | 2021 |
Dobutamine Instead of Isoproterenol for Atrial Triggers.
Topics: Atrial Fibrillation; Catheter Ablation; Dobutamine; Humans; Isoproterenol; Pulmonary Veins | 2020 |
Quercetin prevents isoprenaline-induced myocardial fibrosis by promoting autophagy via regulating miR-223-3p/FOXO3.
Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Autophagy; Autophagy-Related Proteins; Case-Control | 2021 |
Clinical value of induction protocol after second generation cryoballoon ablation for paroxysmal atrial fibrillation.
Topics: Adrenergic beta-Agonists; Adult; Aged; Atrial Fibrillation; Catheter Ablation; Cryosurgery; Electric | 2018 |
Comparison of the origin and coupling interval between ectopy with and without atrial fibrillation initiation.
Topics: Aged; Atrial Fibrillation; Cardiac Complexes, Premature; Cardiotonic Agents; Catheter Ablation; Fema | 2018 |
Mechanism for Triggered Waves in Atrial Myocytes.
Topics: Animals; Atrial Fibrillation; Calcium Signaling; Dogs; Heart Atria; Isoproterenol; Models, Biologica | 2017 |
Atrial fibrillation occurring during head-up tilt testing: Once detected, atrial fibrillation should be monitored, regardless of how it is detected.
Topics: Adult; Aged; Atrial Fibrillation; Cardiotonic Agents; Electrocardiography; Female; Humans; Isoproter | 2019 |
Histone deacetylase inhibition attenuates atrial arrhythmogenesis in sterile pericarditis.
Topics: Acetylcholine; Action Potentials; Animals; Atrial Fibrillation; Collagen; Disease Models, Animal; El | 2018 |
Exchange-protein activated by cAMP (EPAC) regulates L-type calcium channel in atrial fibrillation of heart failure model.
Topics: Animals; Atrial Fibrillation; Calcium Channels, L-Type; Cells, Cultured; Disease Models, Animal; Ele | 2019 |
The hunt for nonpulmonary vein triggers and acute pulmonary vein reconnections.
Topics: Adenosine; Atrial Fibrillation; Electrophysiologic Techniques, Cardiac; Female; Humans; Isoprotereno | 2013 |
Acute pulmonary vein reconnection is a predictor of atrial fibrillation recurrence following pulmonary vein isolation.
Topics: Adenosine; Atrial Fibrillation; Cardiotonic Agents; Catheter Ablation; Female; Heart Conduction Syst | 2014 |
Idiopathic ventricular fibrillation associated with early repolarization which was unmasked by a sodium channel blocker after catheter ablation of atrial fibrillation.
Topics: Atrial Fibrillation; Catheter Ablation; Electrocardiography; Female; Follow-Up Studies; Humans; Inje | 2014 |
Right-to-left frequency gradient during atrial fibrillation initiated by right atrial ectopies and its augmentation by adenosine triphosphate: Implications of right atrial fibrillation.
Topics: Adenosine Triphosphate; Adult; Aged; Atrial Fibrillation; Atrial Premature Complexes; Cardiovascular | 2016 |
Association between dissociated firing in isolated pulmonary veins and the initiation and maintenance of atrial fibrillation.
Topics: Action Potentials; Atrial Fibrillation; Biological Clocks; Chronic Disease; Electrocardiography; Fem | 2016 |
Ectopies from the superior vena cava after pulmonary vein isolation in patients with atrial fibrillation.
Topics: Action Potentials; Adrenergic beta-Agonists; Aged; Atrial Fibrillation; Atrial Premature Complexes; | 2016 |
VLDL from Metabolic Syndrome Individuals Enhanced Lipid Accumulation in Atria with Association of Susceptibility to Atrial Fibrillation.
Topics: Adult; Animals; Apoptosis; Atrial Fibrillation; Cardiac Output; Cardiotonic Agents; Diastole; Diseas | 2016 |
Gap junction modifiers regulate electrical activities of the sinoatrial node and pulmonary vein: Therapeutic implications in atrial arrhythmogenesis.
Topics: Action Potentials; Aminoquinolines; Animals; Atrial Fibrillation; Cardiovascular Agents; Gap Junctio | 2016 |
Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure.
Topics: Abietanes; Acetylcholine; Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; A | 2016 |
Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.
Topics: Acetylcholine; Action Potentials; Animals; Antazoline; Anti-Arrhythmia Agents; Atrial Fibrillation; | 2017 |
On the mechanisms of arrhythmias in the myocardium of mXinalpha-deficient murine left atrial-pulmonary veins.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atropine; Cardiotonic Agents; Cell Communicati | 2008 |
Localization of atrial fibrillation triggers in patients undergoing pulmonary vein isolation: importance of the carina region.
Topics: Adrenergic beta-Agonists; Aged; Atrial Fibrillation; Catheter Ablation; Electric Countershock; Femal | 2008 |
Influence of autonomic stimulation on the genesis of atrial fibrillation in remodeled canine atria not the same as in normal atria.
Topics: Action Potentials; Animals; Atrial Fibrillation; Atrioventricular Node; Cardiotonic Agents; Catheter | 2009 |
Potent antiarrhythmic effects of chronic amiodarone in canine pulmonary vein sleeve preparations.
Topics: Acetylcholine; Action Potentials; Adrenergic beta-Agonists; Amiodarone; Animals; Anti-Arrhythmia Age | 2009 |
Why amiodarone is better: another piece of the puzzle.
Topics: Acetylcholine; Action Potentials; Adrenergic beta-Agonists; Amiodarone; Animals; Anti-Arrhythmia Age | 2009 |
Mechanisms of stretch-induced atrial fibrillation in the presence and the absence of adrenocholinergic stimulation: interplay between rotors and focal discharges.
Topics: Acetylcholine; Adrenergic beta-Agonists; Animals; Atrial Fibrillation; Cholinergic Agents; Disease M | 2009 |
Mechanisms of sinoatrial node dysfunction in a canine model of pacing-induced atrial fibrillation.
Topics: Adrenergic beta-Agonists; Animals; Atrial Fibrillation; Caffeine; Calcium; Calcium Channels, L-Type; | 2010 |
Multiple arrhythmogenic foci associated with the development of perpetuation of atrial fibrillation.
Topics: Atrial Fibrillation; Cardiac Catheterization; Catheter Ablation; Electrophysiologic Techniques, Card | 2010 |
Cellular basis for atrial fibrillation in an experimental model of short QT1: implications for a pharmacological approach to therapy.
Topics: Action Potentials; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atri | 2010 |
Pseudoatrial fibrillation.
Topics: Adult; Atrial Fibrillation; Bundle of His; Cardiotonic Agents; Catheter Ablation; Electrocardiograph | 2010 |
Arrhythmogenic foci and the mechanisms of atrial fibrillation.
Topics: Action Potentials; Animals; Atrial Fibrillation; Dogs; Electrophysiologic Techniques, Cardiac; Heart | 2010 |
Electrophysiological characteristics of the Marshall bundle in humans.
Topics: Atrial Fibrillation; Body Surface Potential Mapping; Cardiac Pacing, Artificial; Catheter Ablation; | 2010 |
Complex interactions between the sinoatrial node and atrium during reentrant arrhythmias in the canine heart.
Topics: Acetylcholine; Animals; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Dogs; Heart | 2010 |
Sex differences in the electrophysiological characteristics of pulmonary veins and left atrium and their clinical implication in atrial fibrillation.
Topics: Acetylcholine; Action Potentials; Adenosine; Animals; Atrial Fibrillation; Autonomic Nervous System; | 2011 |
Differential effectiveness of pharmacological strategies to reveal dormant pulmonary vein conduction: a clinical-experimental correlation.
Topics: Adenosine; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiotonic Agents; Catheter Ablati | 2011 |
Ablation: search and destroy dormant gaps awakened by adenosine.
Topics: Adenosine; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiotonic Agents; Female; Humans; | 2011 |
Abnormal response of superior sinoatrial node to sympathetic stimulation is a characteristic finding in patients with atrial fibrillation and symptomatic bradycardia.
Topics: Adrenergic beta-Agonists; Adult; Aged; Analysis of Variance; Atrial Fibrillation; Bradycardia; Cardi | 2011 |
Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.
Topics: Acetanilides; Action Potentials; Adrenergic beta-Agonists; Animals; Anisoles; Anti-Arrhythmia Agents | 2012 |
Genetic suppression of Gαs protein provides rate control in atrial fibrillation.
Topics: Adrenergic beta-Agonists; Animals; Atrial Fibrillation; Atrioventricular Node; Cardiac Pacing, Artif | 2012 |
Dormant conduction revealed by adenosine to guide electrical isolation of the superior vena cava.
Topics: Adenosine; Atrial Appendage; Atrial Fibrillation; Cardiotonic Agents; Catheter Ablation; Heart Condu | 2012 |
Development of rapid preexcited ventricular response to atrial fibrillation in a patient with intermittent preexcitation.
Topics: Accessory Atrioventricular Bundle; Adrenergic beta-Agonists; Atrial Fibrillation; Catheter Ablation; | 2013 |
Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation.
Topics: Action Potentials; Adipocytes; Animals; Atrial Fibrillation; Heart Atria; Isoproterenol; Male; Myocy | 2012 |
Alternating RBBB and LBBB post-AV node ablation: what is the mechanism?
Topics: Adrenergic beta-Agonists; Atrial Fibrillation; Atrioventricular Node; Bundle-Branch Block; Cardiomyo | 2012 |
Mechanisms of human atrial fibrillation initiation: clinical and computational studies of repolarization restitution and activation latency.
Topics: Action Potentials; Adenosine; Adrenergic beta-Agonists; Adult; Aged; Anti-Arrhythmia Agents; Atrial | 2012 |
Chronic atrial fibrillation up-regulates β1-Adrenoceptors affecting repolarizing currents and action potential duration.
Topics: Action Potentials; Aged; Atrial Fibrillation; Chronic Disease; Female; Heart Atria; Humans; Isoprote | 2013 |
Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure.
Topics: Acetanilides; Acetylcholine; Animals; Atrial Fibrillation; Disease Models, Animal; Electrocardiograp | 2012 |
Inducibility of atrial fibrillation and flutter following pulmonary vein ablation.
Topics: Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Female; Follow-Up Studies; Humans; Isoproter | 2013 |
Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Function; Cardiac Paci | 2003 |
Pacing-induced spontaneous activity in myocardial sleeves of pulmonary veins after treatment with ryanodine.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Atrial Fibrillation; Atrial Function; Calcium; | 2003 |
P wave polarities of an arrhythmogenic focus in patients with paroxysmal atrial fibrillation originating from superior vena cava or right superior pulmonary vein.
Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; | 2003 |
Dual AV nodal pathways and conduction during atrial fibrillation.
Topics: Adrenergic beta-Agonists; Adult; Atrial Fibrillation; Atrioventricular Node; Catheter Ablation; Elec | 2003 |
ADAMS-STOKES SYNDROME DURING ATRIAL FIBRILLATION WITH A-V BLOCK: OBSERVATIONS ON TOXIC REACTIONS TO DIGITALIS.
Topics: Adams-Stokes Syndrome; Atrial Fibrillation; Digitalis; Digitalis Glycosides; Digitoxin; Drug Therapy | 1964 |
[CLINICAL ASPECTS AND TREATMENT OF LIFE THREATENING CARDIAC ARRHYTHMIAS].
Topics: Adams-Stokes Syndrome; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Drug | 1964 |
[CLINICAL ASPECTS AND TREATMENT OF LIFE THREATENING CARDIAC ARRHYTHMIAS].
Topics: Adams-Stokes Syndrome; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Drug | 1964 |
PREVENTION OF VENTRICULAR TACHYCARDIA AND STOKES-ADAMS SEIZURES IN COMPLETE HEART BLOCK; TREATMENT WITH LARGE DOSES OF INTRAVENOUS ISOPROTERENOL.
Topics: Adams-Stokes Syndrome; Atrial Fibrillation; Drug Therapy; Electrocardiography; Geriatrics; Heart Blo | 1965 |
Atrial fibrillation originating from persistent left superior vena cava.
Topics: Adrenergic beta-Agonists; Adult; Atrial Fibrillation; Atrial Premature Complexes; Cardiac Catheteriz | 2004 |
Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs.
Topics: Acetylcholine; Adrenergic Agonists; Adrenergic Antagonists; Animals; Atrial Fibrillation; Atropine; | 2004 |
Relation between pulmonary vein firing and extent of left atrial-pulmonary vein connection in patients with atrial fibrillation.
Topics: Action Potentials; Adrenergic beta-Agonists; Atrial Fibrillation; Cardiac Catheterization; Catheter | 2004 |
P wave separation after atrial compartment operation for atrial fibrillation.
Topics: Adult; Atrial Fibrillation; Electrocardiography; Female; Heart Atria; Heart Conduction System; Human | 2004 |
Effect of heart rate and isoproterenol on pulmonary vein flow velocity following radiofrequency ablation: a Doppler color flow imaging study.
Topics: Adrenergic beta-Agonists; Adult; Atrial Fibrillation; Blood Flow Velocity; Bronchodilator Agents; Ca | 2004 |
Intracoronary endothelin-1 infusion combined with systemic isoproterenol treatment: antagonistic arrhythmogenic effects.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Atrial Fibrillation; Blood Pressure; Coronary | 2004 |
Electrophysiological findings in adolescents with atrial fibrillation who have structurally normal hearts.
Topics: Adolescent; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Child; Combined Modality | 2004 |
L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases.
Topics: Aged; Atrial Fibrillation; Calcium Channels, L-Type; Chronic Disease; Down-Regulation; Electric Cond | 2004 |
Assessment of the dynamics of atrial signals and local atrial period series during atrial fibrillation: effects of isoproterenol administration.
Topics: Atrial Fibrillation; Electrocardiography; Female; Heart Atria; Humans; Isoproterenol; Male; Middle A | 2004 |
Presence of left-to-right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans.
Topics: Adrenergic beta-Agonists; Aged; Atrial Fibrillation; Cardiac Catheterization; Chronic Disease; Coron | 2004 |
Response to pharmacological challenge of dissociated pulmonary vein rhythm.
Topics: Adenosine; Atrial Fibrillation; Female; Humans; Isoproterenol; Male; Middle Aged; Phenylephrine; Pul | 2005 |
Atrial fibrillation in KCNE1-null mice.
Topics: Action Potentials; Animals; Atrial Fibrillation; Disease Susceptibility; Isoproterenol; Mice; Mice, | 2005 |
High efficiency activation of L-type Ca2+ current by 5-HT in human atrial myocytes.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Calcium; Calcium C | 2004 |
Heterogeneous pulmonary vein myocardial cell repolarization implications for reentry and triggered activity.
Topics: Animals; Atrial Fibrillation; Atrial Function; Cardiac Pacing, Artificial; Heart Atria; Isoprotereno | 2005 |
Catheter ablation of atrial fibrillation originating from superior vena cava.
Topics: Adult; Atrial Fibrillation; Catheter Ablation; Female; Humans; Infusions, Intravenous; Isoproterenol | 2006 |
Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic.
Topics: Action Potentials; Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; | 2006 |
[Inducibility of atrial arrhythmias after adenosine and isoproterenol infusion in patients referred for atrial fibrillation ablation].
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Data Interpretation, Statistical; Electrophysiolo | 2006 |
Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation.
Topics: Action Potentials; Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Calcium Channels, L-Type; | 2007 |
Assessment of spatial organization in the atria during paroxysmal atrial fibrillation and adrenergic stimulation.
Topics: Adrenergic beta-Agonists; Algorithms; Atrial Fibrillation; Computer Simulation; Diagnosis, Computer- | 2006 |
Calmodulin kinase II inhibition prevents arrhythmic activity induced by alpha and beta adrenergic agonists in rabbit pulmonary veins.
Topics: Action Potentials; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Age | 2007 |
Interest of non-invasive and semi-invasive testings in asymptomatic children with pre-excitation syndrome.
Topics: Adolescent; Adult; Atrial Fibrillation; Cardiology; Child; Death, Sudden, Cardiac; Electrophysiologi | 2007 |
Adrenergic regulation of a key cardiac potassium channel can contribute to atrial fibrillation: evidence from an I Ks transgenic mouse.
Topics: Adrenergic beta-Agonists; Animals; Atrial Fibrillation; Computer Simulation; Electrocardiography; El | 2008 |
Prognostic implication of the left atrial appendage mechanical reserve after cardioversion of atrial fibrillation.
Topics: Adult; Aged; Atrial Appendage; Atrial Fibrillation; Blood Flow Velocity; Cardiotonic Agents; Chronic | 2008 |
Atrial fibrillation induction with isoproterenol: teaching an old drug new tricks.
Topics: Adrenergic beta-Agonists; Adult; Atrial Fibrillation; Dose-Response Relationship, Drug; Electrocardi | 2008 |
[Life-threatening disorders of the heart rhythm and beta receptor blocking agents].
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Female; Humans; Isoproterenol; Mal | 1967 |
Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
Topics: Ajmaline; Amiodarone; Atrial Fibrillation; Benzofurans; Electrophysiology; Heart; Humans; Isoprotere | 1983 |
Effects of exercise and isoproterenol during atrial fibrillation in patients with Wolff-Parkinson-White syndrome.
Topics: Atrial Fibrillation; Exercise Test; Humans; Isoproterenol; Risk; Ventricular Fibrillation; Wolff-Par | 1983 |
Value of oesophageal pacing in evaluation of atrial arrhythmias.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arrhythmia, Sinus; Atrial Fibrillation; Atrial Flutter; | 1994 |
[Paroxysmal atrial fibrillation: main cause of syncope in hypertrophic cardiomyopathy].
Topics: Adult; Aged; Ajmaline; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardio | 1993 |
Mechanism of the suppression of repetitive atrial firing by isoproterenol--comparison with disopyramide.
Topics: Adult; Atrial Fibrillation; Atrial Function; Disopyramide; Electric Stimulation; Electrocardiography | 1994 |
Role of autonomic reflexes in syncope associated with paroxysmal atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Autonomic Nervous System; Blood Pressure; Cardiac Pacing, Artificial; Car | 1993 |
Refractory postoperative torsades de pointes syndrome successfully treated with isoproterenol.
Topics: Atrial Fibrillation; Coronary Artery Bypass; Female; Humans; Internal Mammary-Coronary Artery Anasto | 1993 |
Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular N | 1996 |
Ventricular rate during atrial fibrillation before and after slow-pathway ablation. Effects of autonomic blockade and beta-adrenergic stimulation.
Topics: Adult; Aged; Atrial Fibrillation; Atropine; Catheter Ablation; Female; Heart Rate; Humans; Isoproter | 1996 |
Mechanism of ventricular rate control after radiofrequency modification of atrioventricular conduction in patients with atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Atrioventricular Node; Cardiac Pacing, Artificial; Cardiotonic Age | 1996 |
Abnormal vasovagal reaction, autonomic function, and heart rate variability in patients with paroxysmal atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Atrial Fibrillation; Autonomic Nervous System; | 1998 |
Physiology of the escape rhythm after radiofrequency atrioventricular junctional ablation.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Atropine; Bundl | 1998 |
Effect of ethanol drinking, hangover, and exercise on adrenergic activity and heart rate variability in patients with a history of alcohol-induced atrial fibrillation.
Topics: Adrenergic beta-Agonists; Adult; Alcohol Drinking; Atrial Fibrillation; Catecholamines; Cyclic AMP; | 1998 |
Effect of increased parasympathetic and sympathetic tone on internal atrial defibrillation thresholds in humans.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Atropine; | 1999 |
Calcium sensitivity and the effect of the calcium sensitizing drug pimobendan in the alcoholic isolated rat atrium.
Topics: Alcohol Drinking; Animals; Atrial Fibrillation; Calcium; Cardiotonic Agents; Dose-Response Relations | 1999 |
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination.
Topics: Adrenergic beta-Agonists; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; F | 1999 |
Relation between ligament of Marshall and adrenergic atrial tachyarrhythmia.
Topics: Animals; Atrial Fibrillation; Dogs; Heart Atria; Histocytochemistry; In Vitro Techniques; Isoprotere | 1999 |
Atrial L-type Ca2+ currents and human atrial fibrillation.
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Ca | 1999 |
Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids.
Topics: Animals; Atrial Fibrillation; Benzyl Alcohol; Cardiac Pacing, Artificial; Cell Survival; Cells, Cult | 2000 |
Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation.
Topics: Acetylcholine; Action Potentials; Adenosine; Adrenergic beta-Antagonists; Animals; Arrhythmias, Card | 2000 |
Double potentials in the right superior pulmonary vein.
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Atrial Fibrillation; Cardiac Complexes, Prematur | 2000 |
L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2001 |
Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Pacing, Artificial; D | 2001 |
Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Atrial Appendage; Atrial Fibrillation; Calcium; Electri | 2002 |
[Isoproterenol potentiates atrial fibrillation induced by acetylcholine].
Topics: Acetylcholine; Adrenergic beta-Agonists; Animals; Atrial Fibrillation; Cholinergic Agents; Dogs; Dru | 2001 |
Electrophysiology of single cardiomyocytes isolated from rabbit pulmonary veins: implication in initiation of focal atrial fibrillation.
Topics: Acetylcholine; Action Potentials; Animals; Atrial Fibrillation; Cell Size; Cells, Cultured; Electric | 2002 |
Effect of low-dose isoproterenol infusion on left atrial appendage function soon after cardioversion of chronic atrial tachyarrhythmias.
Topics: Aged; Atrial Appendage; Atrial Fibrillation; Atrial Flutter; Atrial Function, Left; Cardiotonic Agen | 2002 |
Experiments in animals on the pharmacological effects of metipranolol in comparison with propranolol and pindolol.
Topics: Adrenergic beta-Antagonists; Animals; Atrial Fibrillation; Cornea; Gluconeogenesis; Heart; Hypoxia; | 1977 |
Verapamil-induced ventricular regularity in atrial fibrillation. Effects of exercise, isoproterenol, atropine and conversion to sinus rhythm.
Topics: Adult; Aged; Atrial Fibrillation; Atropine; Electrocardiography; Exercise Test; Female; Heart Rate; | 1979 |
Evaluation of myocardial contractility by the non-invasive method.
Topics: Aged; Atrial Fibrillation; Blood Pressure; Cardiac Output; Depression, Chemical; Digitalis Glycoside | 1975 |
Roles of the AV junction in determining the ventricular response to atrial fibrillation.
Topics: Acetylcholine; Animals; Atrial Fibrillation; Atrioventricular Node; Dogs; Electrocardiography; Gluca | 1975 |
[Proceedings: Sinus bradycardia and sino-atrial conduction].
Topics: Adult; Aged; Atrial Fibrillation; Bradycardia; Electric Stimulation; Female; Humans; Isoproterenol; | 1975 |
The effects of acetylstrophanthidin on the response of the AV junction to adrenergic stimulation studied in dogs.
Topics: Animals; Atrial Fibrillation; Atrioventricular Node; Electric Stimulation; Heart Block; Heart Conduc | 1976 |
Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol.
Topics: Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrocardiography; Female; Heart Conductio | 1992 |
Comparison of isoproterenol and exercise tests in asymptomatic subjects with Wolff-Parkinson-White syndrome.
Topics: Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrophysiology; Exercise Test; Heart Cond | 1992 |
Differentiation of sinus rhythms from supraventricular tachydysrhythmias by activation sequence and timing.
Topics: Animals; Atrial Fibrillation; Atrial Flutter; Atrial Function, Left; Atrioventricular Node; Bloodlet | 1990 |
[Electrophysiological characteristics of asymptomatic Wolff-Parkinson-White syndromes].
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Electrophy | 1991 |
Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Dogs; El | 1991 |
Reflex control of sympathetic nerve activity in dopamine beta-hydroxylase deficiency.
Topics: Adult; Atrial Fibrillation; Blood Pressure; Cold Temperature; Dopamine beta-Hydroxylase; Electrophys | 1990 |
Parasympathetically modulated antiarrhythmic action of lidocaine in atrial fibrillation.
Topics: Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Dogs; Electric Stimulation; Electrocar | 1990 |
Appropriate diagnostic studies for sinus node dysfunction.
Topics: Atrial Fibrillation; Atropine; Autonomic Nervous System; Bradycardia; Cardiac Pacing, Artificial; Ca | 1985 |
Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Drug Therapy, C | 1988 |
Usefulness of isoproterenol during atrial fibrillation in evaluation of asymptomatic Wolff-Parkinson-White pattern.
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Death, Sudden; Electrophysiology; Evaluation Studies a | 1989 |
The effect of drugs and lead maturation on atrial electrograms during sinus rhythm and atrial fibrillation.
Topics: Algorithms; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Dogs; | 1989 |
Intermittent Wolff-Parkinson-White syndrome due to phase 3 and phase 4 block: disappearance of rapid ventricular response during atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrocardiography; Heart Block; Heart Condu | 1988 |
Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.
Topics: Animals; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Dogs; Electrocardiography; | 1987 |
Current concepts in sick sinus syndrome. II. ECG manifestation and diagnostic and therapeutic approaches.
Topics: Atrial Fibrillation; Atropine; Bradycardia; Cardiac Pacing, Artificial; Electric Stimulation; Electr | 1985 |
[Clinical studies with a new beta receptor blocking agent from the indole series (LB 46)].
Topics: Adolescent; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Atrial Fibrillation; Atrial | 1970 |
[The effect of d-propranolol on cardiac arrhythmias].
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Asthma; Atrial Fibrillation; Bronchial Spasm; Cardiac | 1969 |
[Treatment of rhythm disorders and cardiac arrest].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bradycardia; Cardiac Complexes, Premature | 1970 |
Influence of calcium and magnesium ions on the sino-atrial node pacemaker activity of the canine heart.
Topics: Acetylcholine; Animals; Atrial Fibrillation; Atropine; Blood Pressure; Calcium; Coronary Circulation | 1974 |
[Thoughts on 125 cases of complete auriculo-ventricular blocks].
Topics: Aged; Atrial Fibrillation; Bradycardia; Cardiac Catheterization; Electric Countershock; Ephedrine; E | 1969 |
Anti-fibrillary and anti-adrenaline activity of beta-receptor blocking drugs.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cats; Epinephrine; Ethanolamines; Gu | 1967 |
Treatment of atrial arrhythmias with alprenolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amino Alcohols; Arrhythmias, Cardiac; Atrial Fibrillation; | 1970 |
Relation of left ventricular diastolic and lung vascular pressures: atrial effects.
Topics: Adrenergic beta-Antagonists; Anesthesia, Spinal; Animals; Atrial Fibrillation; Atrial Function; Bloo | 1971 |
Evaluation of the pulse-contour method of determining stroke volume in man.
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Arrhythmia, Sinus; Atrial Fibrillation; C | 1972 |
Ischaemic heart disease in the elderly.
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Atrial Fibrillation; Coronary Disease; Digitalis Glycos | 1972 |
Idiopathic pulmonary hemosiderosis. Case report with pulmonary function tests and cardiac catheterization data.
Topics: Adult; Atrial Fibrillation; Autopsy; Bone Marrow; Carbon Dioxide; Cardiac Catheterization; Heart Fai | 1972 |
Ejection time by ear densitogram and its derivative. Clinical and physiologic applications.
Topics: Adult; Aged; Aortic Valve Insufficiency; Aortic Valve Stenosis; Atrial Fibrillation; Cardiac Output; | 1973 |
Evaluation of several methods for computing stroke volume from central aortic pressure.
Topics: Analog-Digital Conversion; Animals; Aorta; Atrial Fibrillation; Blood Flow Velocity; Blood Pressure; | 1973 |
Learned control of ventricular rate in patients with atrial fibrillation.
Topics: Adult; Atrial Fibrillation; Atropine; Conditioning, Operant; Edrophonium; Electrocardiography; Femal | 1973 |
Ventricular function in patients with atrial fibrillation. A simulation model study with the aid of a computer.
Topics: Atrial Fibrillation; Atropine; Computers; Coronary Disease; Electrocardiography; Exercise Test; Hear | 1973 |
Prospective study on the occurrence and management of chronic sinoatrial disease, with follow-up.
Topics: Arrhythmia, Sinus; Atrial Fibrillation; Atropine; Digitalis; Electrocardiography; Female; Heart Bloc | 1974 |
[Emergency situations caused by heart arrhythmias within the scope of internal medicine].
Topics: Adams-Stokes Syndrome; Adult; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Electric Co | 1969 |
[Treatment of rhythm disorders in early results of open heart surgery].
Topics: Acid-Base Equilibrium; Acidosis, Respiratory; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiovascu | 1969 |
Treatment of refractory supraventricular arrhythmias with induced permanent atrial fibrillation.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Bradycardia; Cardiac Catheterization; Digitalis | 1971 |
Sinus bradycardia.
Topics: Adolescent; Adult; Aged; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Bra | 1971 |
Applications of the catheter-tip electromagnetic velocity probe in the study of the central circulation in man.
Topics: Adult; Aorta; Atrial Fibrillation; Blood Flow Velocity; Blood Pressure; Cardiac Catheterization; Car | 1970 |
Atrial fibrillation. I.
Topics: Aged; Atrial Fibrillation; Digoxin; Epinephrine; Humans; Hyperthyroidism; Isoproterenol; Male; Middl | 1971 |
Documentation of transient arrhythmias by constant cardiac monitoring.
Topics: Adams-Stokes Syndrome; Adult; Atrial Fibrillation; Bundle-Branch Block; Digitalis Glycosides; Electr | 1965 |
[On treatment of rhythmic disorders in recent myocardial infarct].
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Electrocardiography; Female; Heart | 1966 |